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CHAPTER I 
INTRODUCTION 
Tumor Suppressor Genes 
Cancer is the result of an accumulation of mutations that disrupt the homeostasis 
within a cell. Cancer cells posses the characteristics of continuous growth and an inability 
to widergo tenninal differentiation (Lee, 1993). Normal cells require the interaction of 
positive and negative signals to maintain the balance. Positive signals are those responsible 
for promoting cell growth. Negative signals restrain cell growth. 
The group of genes playing an essential role in negative signaling are described as 
recessive oncogenes, anti-oncogenes, or tumor suppressor genes (Lee, 1993; Klein,1993). 
Tumor suppressor genes act in normal cells to suppress cellular proliferation. The loss of 
tumor suppressor genes from a cell will remove normal constraints on cell growth. Tumor 
suppression was initially identified by somatic cell hybridi7.ation studies (Hanis et al., 1969; 
Klein et al., 1971; Weiner et al., 1974). Fusion of normal cells to highly malignant cells 
resulted in the formation of stable hybrids. The hybrids contained normal chromosome 
complements and expressed the phenotype of the normal cell (Stanbridge et al., 1982). 
Other investigators (Stanbridge et al., 1981; Klinger et al., 1982) fowid a correlation of 
particular chromosomes with suppression of the tumorigenic phenotype. They used the 
HeLa x fibroblast hybrids to identify the chromosome ( or chromosomes) responsible for 
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the nontumorigenic phenotype. Stanbridge (1981) demonstrated that after repeated 
inocula1ion of serially cultivated nontumorigenic hybrids into nude mice, tumorigenic 
segregants did appear. Comparison of chromosomal karyotypes between the 
nontwnorigenic hybrids and their tumorigenic segregants revealed that loss of one copy 
each of both chromosomes 11 and 14, with a high degree of statistical significance, 
comlated with reexpression oftumorigenicity. Klinger (1982) reported similar findings, 
and chromosome 11 showed this same correlation with tumorigenicity. The current isolated 
and characterized human suppressor genes include the Rb (re1inoblastoma), pS3, WI' 
(Wilms' Tumor gene), NFl (neuro:fibl'.omatosis type 1 gene), APC (adenomatous polyposis 
coli), DCC ( deleted-in-colon-carcinoma gene) and DPC ( delited in pancreatic cancer) 
(reviewed by Lee, 1993). 
Retinoblastoma 
A prototype biological model for the study of tumor suppressor genes is the 
retinoblastoma gene. Retinoblasts are the precursors of ceDs in the retina, the light sensitive 
screen at the back of the eye. Retinoblasts are destined to become the photoreceptor cells 
called cones which seem to be involved in retinoblastoma. In humans, a re1inoblast 
differentiates to fonn a specialized re1inal cell, it stops dividing and can no longer serve as a 
target for tumorigenesis (Weinber& 1988). 
Re1inoblastoma is a malignancy of the eye occurring in infants and young children 
(1 in 20,000 children). It exists in both a familial (hereditary) and a sporadic fonn 
(Knudson, 1971 ). In familial re1inobJastoma, deletion of one copy of the re1inoblastoma 
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(Rb) gene in the germ line predisposes an individual to the cancer, and a second mutation 
in the nonnal gene causes eye tumors. Sporadic retinoblastoma is due to somatic 
mutations in both copies of the Rb gene. The fact that loss of both functional copies of the 
Rb gene widerlies tumor formation suggests that this gene nonnally acts in the reunal cells 
to constrain cell proliferation (Weinberg, 1990). 
Yunis et al. (1978) verified that the band responsible for a predisposition to 
retinoblastoma was in a specific small region on the q amt of chromosome 13 using 
interstitial deletions with two retinoblastoma patients. Other investigators (Sparks et al., 
1980; Benedict et al., 1983; Godbout et al., 1983) also observed that the targets of two 
mutations in retinoblastoma were assigned to the q14 region. on chromosome 13. Through 
the studies of families with hereditacy retinoblastoma and analysis of patients with 
congenital chromosome abnormalities, the genn-line mutation responsible for the 
hereditacy form of retinoblastoma has been assigned to the q14 region on chromosome 13 
and closely linked to an enzyme, esterase D. The fact that this region was closely linked to 
esterase D was based on a successful approach to the isolation of the retinoblastoma gene. 
Molecular Biology of Retinoblastoma 
The retinoblastoma gene was cloned and characterized nearly simultaneously using 
a positional chromosome walking technique by three groups (Friend et al., 1986; Lee et al., 
1987a; Fung et al., 1987). They cloned the correct genetic locus by comparing the 
structural changes in diseased and nonnal cells. Friend et al. (1986) cloned the Rb gene. 
They constructed a cDNA libracy from RNA of a human retinal line using the 
bacteriophage cloning vector lambda gtl 1 and fowid a 4. 7 kilobases (kb) insert by 
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screening. The Rb gene was expressed in many tumors, including neuroblastoma, renal 
carcinoma and melanoma. However, there was no RNA 1ranscript in re1inoblastoma and 
osteosarcoma. Subsequently, the absent ( or abnormal) Rb m.RNA and/or protein was 
reported in other tumor types such as small cell lung cancer (SCLC), breast cancer 
(Harbour et al., 1988; Lee et al., 1988; Ryaard et al., 1990; Yokota et al., 1988), prostate 
cancer (Bookstein et al., 1990), bladder cancer (Logothetis et al., 1992), osteogenic and soft 
1issue sarcomas (Cance et al., 1990), and chronic lymphocyte leukemia (Komblau et al., 
1994). From these observations, it is clear that Rb inactivation may play a key role in the 
pathogenesis of several tumors, not just the exceedingly rare eye tumors. Lee et al. 
(1987a) reported a gene encoding a messenger RNA of 4.6 kb on the basis of 
chromosomal location, homozygous deletion, and tumor-specific alteration in expression. 
Transcription of this gene was abnmmal in six of six re1inoblastomas examined 
(Rb m.RNA was not detectable or expressed variably in amount with a 4.0 kb size). The 
gene contained at least 12 exons distributed in a region of over 100 kb and could encode a 
hypothetical protein of816 amino acids. In 1987, Fung et al. reported a 4.7 kb transcript 
Sixteen of forty retinoblastomas examined had identffiable structural changes of the Rb 
gene including homozygous internal deletions with COITCspOllding 1runcated 1ranscripts. 
They identified possible hot spots for deletion within the Rb genomic locus. In all of the 
internal deletion cases examined, deletions involved either the 7 .5 or 9.8 kb HindJJJ. 
fragments. Mutations in the Rb gene were also reported by Dunn et al. (1989) and 
Horowitz et al. (1989). The mutations involved a small deletion, duplication or point 
mutation in Rb tumors. Lee et al. (1987b) reported a revised Rb cDNA sequence. It still 
maintained the same open reading frame as in the original clones, with an additional 
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methionine codon found at nucleo1ide 139. When this methionine was used as an ini1ia1ion 
codon, the predicted Rb protein had 928 predict amino acids and Mr 110 Kda-iden1ical to 
the apparent Mr by sodium dodecyl sulfate polyacry)amide gel electrophoresis (SDS-
P AGE). 
Hong et al. (1989) and T'Ang et al. (1989) reported the genomic structure of the 
human re1inoblastoma gene. The Rb transcript is encoded in 27 exons dis1nbuted over 
200kb of genomic DNA. The length of individual exons ranges from 31 to 1889 
nucleo1ides. The largest intron is more than 60 kb and the smallest one has 80 bp. Exon 1 
contains 5' untranslated sequences and encodes the first methionine. A 70 base pair 
promotor region which has a G+C rich region is located immediately upstream from the 
first exon. A putative "leucine-.zipper'' motif is exclusively encoded by exon 20. A typical 
upstream TATA box is not present. Toguchida et al. (1993) reported the complete 
genomic sequence of the human Rb gene. They used a directed prime-and-run approach 
to sequence about 180 kb encompassing the human Rb gene. This sequence extends from 
the G in the EcoR I site 2059 bp upstream of the first base of the ini1ia1ion codon to the 
last Tin a HindJIJ. site 3008 bp down stream of the stop codon. Partial analysis of the 
sequence revealed a high (A+ T)/(G+C) ratio and a high density of Line-1 repeat 
sequences. This favors a map loca1ion within a Giemsa-staining chromosome band or 
G-band. The sequence data indicative of a G-band loca1ion suggest an assignment to 
either 13ql4.12 or 13q14.2. Toguchida et al. (1993) also found interspersed, repetitive 
DNA sequences (46Alu and 17 Line -1 repeat sequence) within thel80 kb contig. 
The Rb cDNAs from mouse, fro& rat, and chicken have also been cloned 
(Bernards et al., 1989; Destree et al., 1992; Roy et al., 1993; Feinstein et al., 1994). In 
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1989, Bernards et al isolated a cDNA clone of the murine homolog of the human 
reunoblastoma susceptibility gene. The leng1h of the DNA was 4592 bp and it had an 84% 
similarity to the human Rb cDNA The degree of conservation in the coading region 
(88. 7%) was not much higher than the degree of conservation in the 3' untranslated region 
of the cDNA (77.3%). The 3' untranslated region of both the mouse and the human Rb 
cDNA contained a total of 12 ATTA mo1ifs. The Rb cDNA contained a single large open 
reading frame from nucleotide 99 to a stop codon at nucleotide 2865. The predicted 
amino acid sequence of the mouse Rb protein is a 921-amino acid protein with a calculated 
molecular weight of lOSK.da. Co~li. of the predicted amino acid sequence of the 
mouse Rb protein with that of human Rb protein showed that the human Rb protein has a 
total of 7 additional amino acids. In total, 82 of921 amino acids were different between 
mouse and hmnan Rb proteins. This made the two proteins 91 % identical. Bernards et al. 
(1989) also showed the conservation of the Rb gene in closely and distantly related 
organisms (lamprey, shade, swordtail, chicken, mouse, and human) by Southern blot 
analysis of Hindlll-ctigested total genomic DNA usmg the 3.8 kb EcoR I fragment of the 
human Rb gene as a probe. All organisms examined contained sequences that 
crosshybridize with the human Rb gene probe. RNA analyses of the mouse showed a 
4. 7 kb Rb transcript in all 1issues examined. Jrtteresungly, an additional mRNA transcript 
(2.8 kb) was found in the testes of mice as the spennatids mature. 
A Xenopus homolog (XR.b 1) of the human reunoblastoma susceptibility gene was 
cloned by Destree et al. (1992). The nucleotide sequence ofXR.b has 65% similarity to 
that of mouse Rb. The XR.b sequence contains a single open reading frame of 2697 
nucleotides which would encode an 899 amino acid protein. The predicted amino acid 
sequence oftheXenopus re1inoblastoma protein (pXRbl) shows an overall 56% identity 
compared with murine and human Rb proteins. A "leucine-zipper" motif, consensus 
sequences for cdc2 kinase and potential sites for other kinases are conserved. The region 
of the protein homologous to the SV 40 T an1igen binding site and the basic region 
c-terminalto the ElA binding site are aD conserved. There is a 75% amino acid identity 
between the human and theXenopus proteins in the ElA binding domains (A and B). 
There is only a 37% identity of amino acids in the spacer region between the two domains. 
In mouse and human the Rb transcripts are 4.7-kb in size. However, 10 and 4.2 kb 
transcripts are present for all tissues and developmental stages inXenopus. The level of 
expression of the XR.b gene varies greatly for the different tissues. The Xenopus 99-Kda 
protein (pXRbl) was detected using antibodies ( XZ37, XZ78, and XZ160) raised against 
human p105Rb. 
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Roy et al (1993) cloned the rat retinoblastoma cDNA They sequenced a 2.1 kb 
cDNA fragment (R96l). The rat R961 Rb cDNA sequence is homologous to the 3' region 
of mouse and human Rb genes. Homology between rat and mouse is more than 
92%, and between rat and human is approximately 81 %. The amino acid sequence 
deduced from this cDNA is about 97% homologous with that of the human Rb protein 
sequence at the carboxyl terminus. 
Feinstein et al (1994) characterized a chicken cDNA encoding the retinoblastoma 
gene product A full-length chicken Rb cDNA is approximately 4.5 kb and can be divided 
onto three EcoR I fragments of approximately 0.9 kb, 1.6 kb and 2.0 kb. The chicken Rb 
messenger RNA is predicted to contain a short GC-rich 5' nontranslated region followed 
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by an AUG beginning at nucleotide 77 of the cDNA The predicted chicken Rb protein is 
a 919 amino acid protein with a calculated molecular mass of 104 Kda. It is similar to that 
of the mouse, hmnan andXenopus Rb proteins in regions of known fimctions. In 
adenovirus ElA binding sites (amino acids 394-572 and 646-772 of human Rb) all four 
proteins have a total of 66% amino acid identity. However, chicken Rb has distinct 
species-specific differences near the N-tenninus ( from approximately amino acid 5 
through 55 of chicken Rb). The mouse and human Rb proteins are similar in this region, 
the chicken andXenopus Rb protein each have dis1inct sequences. 
The Rb protein was iden1ified by antibodies raised against a tryE-Rb fusion protein 
(Lee et al., 1987a). This protein, termed pll<J8'h, migrates as mu11iple closely-spaced bands 
between Mr 110 to 116 Kda when sized on denaturing po)yacry)amide gels. The protein 
Rb is a phosphoprotein and is located within the nucleus. The protein can be retained by 
and eluted from DNA-cellulose columns, suggesting that the protein has DNA binding 
activity. It is present in all cell lines expressing nonnal mRNA, but is absent from five 
retinoblastoma cell lines examined (Lee et al., 1987b ). 
Distinct domains of the Rb protein are important in understanding its biological 
fimctions. Riley et al. (1994) showed the schematic representation of the s1ructure of the 
human Rb protein in the review paper as illustrated in figure 1. The Rb protein is 
organized into at least three distinct s1ructural domains. The N-terminal domain (N) is 
important for oligomerization in vitro (Hensey et al., 1994). Two other domains 
(A and B) are frequently altered in hmnan tumors (Hu et al., 1990; Huang et al., 1990) 
and are required for the binding of E2F. Several DNA tumor virus oncoproteins such as 
adenovirus El A, SV 40 large T antigen and hmnan papillomavirus E7 protein can also bind 
to these domains (CheDappan et al., 1992). These domains are also referred to as the 
"pocket " because they serve as receptors for proteins of a specific class (Kaelin et al., 
1991 ). Nonspecific DNA binding is in1rinsic to the carboxyl-terminal portion of the 
protein (Wang et al., 1990). 
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The Rb protein has been reported to be a phosphoprotein by biochemical studies 
(Lee et al., 1987b; Chen et al., 1989). Disunct electrophoretic bands migrating from 110 
to 116 Kda have been shown to correspond to different phosphmylated forms of pll<fl' 
(Xu et al., 1989; Ludlow et al., 1989). In nonnal ceDs, the Rb protein is expressed 
throughout the cell cycle but its func1ionally active states are detennined by the degree of 
phosphorylation (DeCaprio et al., 1989; Chen et al., 1989; Ludlow et al., 1990). The 
wider (wi)phosphoiylated Rb forms are present in G0 and G1• These fonns seem to be 
involved in preventing the cell from widetgoing transi1ion from G1 to S. Laiho et al. 
(1990) reported that TGF-(31 acts to retain Rb in the widerphosphmylated growth-
suppressive state. Whereas the more highly phosphmylated forms are fowid during S and 
GM phases. The progressive phosphoiylation of the Rb protein seemingly relieves the 
block and allows continuation of the cell cycle. Based on these observations, the 
widerphosphmylated form of the Rb protein appears to have a key role in the growth-
suppressive activity of Rb protein. This is supported by another study of role of the 
retmoblastoma Rb protein. This study was done with the products of DNA tumor viruses. 
Whyte et al. (1988) reported that adenovirus ElA and Rb protein form a specific complex. 
Similarly, DeCaprio et al (1988) and Ludlow et al. (1989) observed that SV40 T forms a 
complex with this protein, pll0-114Rb. Like ElA and SV40 la!ge T, Human papilloma 
virus E7 proteins form a specific complex with.the Rb protein (Dyson et al., 1989; Munger 
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et al., 1989). These oncoproteins inactivate Rb at G1 and allow quiescent cells to enter the 
cell cycle. Shortly, when Rb is complexed with an oncogene product, cons1raints to 
proliferation by activated Rb are removed and the unscheduled cellular proliferation 
characteristic of neoplasia can occur. This ensures that Rb is an anti-oncogene. 
The cell cycle-dependent phosphorylation of Rb protein suggests that it may be a 
substrate of a cell cycle-regulated protein kinase. Recently, the kinases responsible for the 
phosphoiylation of Rb protein have begun to be discovered. The cdc2 kinase (Lin et al., 
1991) and cdc2-like kinase (Kitagawa et al., 1992) can phosphoiylate the Rb protein in 
vitro on many of the same sites nonnally phosphoiylated in vivo. Human cdc2 has also 
been shown to interact physically with Rb protein (Lin et al., 1991 ). Dephosphotylation of 
Rb protein can involve protein phosphatase 1. Durfee et al. (1993) reported that the Rb 
protein binds with the protein phophatase type 1 catalytic subunit. Moreover, 
dephosphorylation of Rb in Mand G1 phases by protein phosphatase 1 has been 
demonstrated by blocking protein phophatase 1 activity using phophatase inlu"bitors 
(Alberts et al., 1993; Kim et al., 1993; Ludlow et al., 1993). 
Many studies have demonstrated that the Rb protein associates with cellular 
proteins. The best characterized cellular Rb-associated protein is the transcription factor 
E2F-1 (Chellappan et al., 1991; Chittenden et al., 1991). Chellappan et al. (1991) showed 
that the Rb protein is found in a complex with the E2F transcription factor and that only 
the underphosphoiylated form of Rb is in the E2F complex. Moreover, E2F and the DNA 
tumor virus oncoproteins bind to the same regions of Rb and the E2F-Rb complex can be 
dissociated by these oncoproteins. Chittenden et al. (1991) reported that a DNA-binding 
site and enrichment procedure revealed a sequence-specific DNA-binding activity 
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selectively associated with glutathionine S-transferase-retinoblastoma protein chimeras 
(OST-RB) that had been incubated with a human cell extract. Appropriate mutant f011DS 
of OST-RB, incubated in equivalent extracts, did not associate this specific DNA-binding 
ac1ivity, and a peptide replica of the HPV E7 Rb binding segment selectively inhibited the 
association of OST-RB with sequence-specific DNA-binding protein. They suggest that 
Rb can associate specifically with the transcription factor E2F by sequence analysis of 
oligonucleotides with high affinity for OST-RB complexes and the results of competition 
binding studies. Results from both researchers suggest that the interaction of Rb with E2F 
is an important event in the control of cellular proliferation. When transcription factors 
are complexed with Rb and inactivated, transcription is inhibited and cell cycle progression 
is blocked. When they are free by oncoproteins, they can activate transcription of genes 
required for the S phase and beyond. 
A family of Rb protein has been discovered based on sequence homologies of 
oncoprotein binding domains of the retinoblastoma. Two other proteins p107 and p130 
have been isolated by their interaction with adenovirus ElA (Harlow et al., 1986; Dyson et 
al., 1989a; Mayol et al., 1993). p107 is a cellular protein which was identified by virtue of 
its ability to bind to the El A, SV 40 and JC virus large T-antigen oncoproteins. Sequence 
analysis of a human p107 cDNA clone identified a region of S64 amino acids with S7% 
identity to the so called "pocket domain" of the human Rb product (Ewen et al., 1991). 
Homology between the p107 and pRb pocket domain resides largely in two regions known 
as the A and B motifs, which are 178 and 124 amino acids in length, respectively. The A 
and B motifs are separated by non-homologous spacers of 211 amino acids in p107 and 73 
amino acids in pRb. A third adenovirus ElA binding protein, designated p130 is 
homologous with p107. Although there is less similarity between p130 and pRb (32%), 
the pocket domain sequence is highly conserved among all three proteins. 
AV ertebrate Model for Re1moblastom 
Although Rb is the best-known of all tumor suppressor genes, researchers are just 
beginning to widerstand the regulation and function of the Rb protein. It is necessary to 
determine how the Rb protein limits or shuts down cell proliferation in nonnal cells. A 
clear widerstanding of the e1hiology of the Rb suppressor gene will provide an answer to 
this question and an opportunity to widerstand the tumorigenesis process in a variety of 
cancers. 
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Studies of re1moblastomas are limited to human autopsy and surgical material 
because of the Jack of a vertebrate model capable of expressing re1inoblastoma. Windle et 
al. (1990) and O'Brien et al. (1990) created a transgenic animal model ofre1inoblastoma. 
In this model, ocular re1moblastoma and central nervous system tumors with histological, 
ultrastructural and immunohistochemical characteris1ics iden1ical to those of the human 
were observed in a mouse fanned by the transgenic expression of the SV 40 T-antigene. 
While this will no doubt be a valuable source of re1moblastoma tissue, owing to the way the 
mouse was engineered, it will not provide a means for widerstanding the genetics 
controlling expression of the disease wider natural conditions. Therefore, we need a model 
to Wlderstand the mechanism of re1inoblastoma involvement in tumorigenesis and other 
tumors wider natural conditions. 
Re1moblastoma protein has been reported in a number of fish species including 
medaka (Oryzias lati~) (Ostrander et al., 1992), coleacanth (Latimeria chalumnae), 
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rainbow trout (Oncorhynchus mykiss), and English sole (Parophyrs vetulus) (Van Beneden 
and Ostrander, 1994 ). Retinoblastomas of several :fishes have been reported as single 
spontaneous cases (Foumie et al., 1985). Furthermore, Hawkins et al. (1986) reported the 
inducibility of intraocular neoplasms in Japanese medaka ( Otyzias latipes ) with 
methylazoxymethanol acetate (MAM-AC). The medaka was the only species to develop 
intraocular neoplasm among seven :fish species examined. Ultimately, some of these 
lesions were detennined to be retinoblastomas (Ostrander et al., 1992). Thus, a vertebrate 
model for retinoblastoma has been established using medaka. The medaka is a small 
aquarium :fish (3-5 cm) that is easily maintained in the laboratory. The entire animal can be 
mounted on a paraffin block or frozen for later sectioning and histochemical analysis. The 
entire :fish can also be exposed to antibodies or probes and all tissues simultaneously 
examined. Finally, retinoblastomas in the medaka can be induced as necessary (100A, + 
incidence). Therefore, we have adequate samples to study retinoblastoma. For these 
reasons, a unique opportunity exists to study the ethiology of this malignancy in another 
vertebrate species. The similar pathology to mammalian models and unique mode of 
induction insure that information relevant to cancer in general will be gleaned from these 
studies. 
The studies detailed below with the medaka provide a :framework to investigate the 
normal function of the Rb protein. These studies form the basis for completion of 
experiments with medaka treated with carcinogens. 
Specifically, I studied: 
1. Detection of Rb mRNA and Rb protein during various developmental stages 
and in various tissues of normal medaka. 
2. Construc1ion and screening of a cDNA library with mRNA from medaka liver. 
3. The effect of growth factors and hormones on the medaka Rb protein. 
CHAPTER II 
DETECTION OF Rb mR.NA AND Rb PROTEIN DURING VARIOUS 
DEVELOPMENTAL STAGES AND INV ARIOUS TISSUES 
OF NORMAL :MEDAKA 
Introduction 
Molecular analyses have shown that the retinoblastoma gene is evolutionarily 
conserved in vertebrates. Lee et al. (1987a) examined genomic DNA from four non-
human vertebrate species by hybridizing with probe RB-5 (3.5 kb Rb cDNA). Under 
standard hybridiution stringencies, homologous sequences were detected in all samples 
(human placenta, calf retina, cat :fibroblasts, mouse NilI 3T3 :fibroblasts and chicken 
embtyo :fibroblasts), with weaker hybrictiz.ation intensity as evolutionary distance increased. 
Bernard et al. (1989) invesngated the extent to which homologues of the human Rb are 
detectable in closely and distantly related organisms. They performed Southern. blot 
analysis of Hindlll-digested genomic DNA from the following organisms: amphioxus, 
brook lamprey, cat-shark, swordtail, chicken, mouse, and human. They used the 3.8-
kilobase (kb) EcoR I fragment of the human Rb cDNA clone as a probe. All DNA 
samples, except for amphioxus, cross-hybridized with the human Rb gene probe. The 
gene is ubiquitously expressed in various organs of the mouse and frog (Bernards et al., 
1989; Des1ree et al., 1992). 
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I hypothesized that the Rb gene exists in the medaka. To determine if medaka 
have the Rb gene and express a message, Southern blot analyses and Northern blot 
analyses were performed using a 505-base pair (bp) fragment from the human Rb cDNA. 
Northern blot analyses were performed to detect Rb mRNA in various organs of the 
medaka. Finally, Western blot analyses were used to detect the expression of Rb protein in 
developmental stages of eggs, fiy, and various organs of adult medaka. 
Materials and Methods 
Animals and Cell Llne--Medaka (Oryzias latipes) used in these studies were 
obtained from ow- breeding colony at Oklahoma State University which was initiated from 
fish obtained from Dr. William Hawkins at the Gulf Coast Research Laboratoiy. Fertilized 
1 day-old eggs were collected eveiy morning and stored at -8S°C. For later stages of egg 
development, the fertilized eggs were placed in embryo rearing solution until the 
appropriate time, then collected and stored at -85°C. For fly, the eggs were raised in 
embryo rearing solution until hatched, then collected and stored at -85°C. Chronic 
myelogenous leukemia cell line (1(562) was pw-chased from American Type Culture 
Collection and used as a Rb-positive control. 
Chemicals--Reagents (IOX PCR buffer, MgCl2, and dNTP) for PCR and 
AmpliTaq polymerase were from Perkin-Elmer Cetus (Branchburg, NJ). USBioclean MP 
Kit and Random Primed DNA Labeling Kit were from United States Biochemical 
Company (Cleveland, OH). TA Cloning™ Kit was from Invitrogen Company (San Diego, 
CA). Wizard Miniprep DNA Purification System, PolyATtract® mRNA Isolation System, 
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human genomic DNA, and Hindlll restriction enzyme were from Promega (Madison, WI). 
Guanidium thiocyanate, diethyl pyrocarbonate (DEP), 5-bromo-4-chloro-3-indolyl-
phosphate (BCIP), and nitro blue tetrazolium (NBT) were from Sigma Chemical Company 
(St. Louis, MO). Monoclonal antibody (Rb Ab-1) against the Rb gene product was from 
Oncogene Science (Cambridge, MA). Alkaline phosphatase-conjugated affinipure rabbit 
anti-mouse lgG (H+L) was from Jackson Immuno Research (Westgrove, PA). Alpha-(32P) 
dCTP (3000Ci/mmol) was from New England Nuclear (Boston, MA). All other reagents 
were of analytical grade or better. 
Hybridization Probe-The 3.8 kb fragment of the human Rb cDNA was donated by 
Dr. Stephen H. Friend and Dr. Robert A. Weinberg. To make a 505 bp fragment 
corresponding to the conserved region of the Rb gene, polymerase chain reaction (PCR) 
was performed using the 3.8 kb fragment as a template. The oligonucleotides for the 
primers were synthesized by the Recombinant DNA/Protein Resource Facility at Oklahoma 
State University. The primer pair consisted of .s• ACTGCACAGTGAA TCCAAAAG 3' 
and .s'TAATAAGATCAAATAAAGGTG 3'. 
The PCR reaction was prepared in a volume of 40 µl containing 10 mM Tris-HCl 
(pH 8.3)-50 mM KCl-0.001 % (wt/vol) gelatin (IX PCR buffer; Perkin-Elmer Cetus, 
Notwalk, CT), 1.5 mM MgCl2, 200 µM dNTP (dATP, dCTP, dGTP, and dTTP), 
2 pmole/µl of each primer, 2 µl of cDNA, and 0.5 U of AmpliTaq polymerase (Perkin-
Elmer Cetus). Amplification was performed using a Perkin-Elmer Cetus GeneAmp PCR 
System 9600. PCR was started at 94°C for 5 min. Then 35 cycles were performed of 1 
min at 94°C, 1 min at 55°C, and 1 min at 72°C. The samples were subjected to a 10 min 
final extension at 72°C at the end of35 cycles. Water was used as a negative control for 
PCR 
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After the amplification was completed, the fragment was purified to clone into a 
vector using USBioclean 1\fl> kit (United States Biochemical Company). The sample was 
electrophoresed on a 1 % low melting agarose gel in T AE buffer. The desired band was 
cut from the low melting agarose gel using a razor blade. The DNA:Agarose block was 
placed into a micro-centrifuge tube, three volumes of 6 M Nal solution were added to the 
agarose gel block and the tube was incubated at 55°C for 3-5 min to dissolve the agarose. 
Five µl of glass powder were added to the DNA:Nal solution for DNA binding. The glass 
powder with the bound DNA was microcentri:fuged for 5-10 sec and rinsed 3 times with 
50% ethanol rinse buffer. After the final centrifugation, the glass powder was suspended 
in 10 µl of sterile water. The DNA was eluted by incubating at 55°C for 2-5 min. The 
tube was microcentrifuged to recover the DNA. One or two µl of the elution was analyzed 
on a 1 % agarose gel with a known concentration of DNA to approximate the concentration 
of the purified DNA. 
After the purification, The PCR :fragment was cloned to a pCR ™ Il vector using the 
TA Cloning™ kit (Invitrogen Company). The TA Cloning™ kit has the advantage that 
Amplitaq polymerase adds single deoxyadenosines to the 3 '-end of an duplex amplified 
fragments. These A-overhangs are used to insert the PCR product into a specifically 
designed vector having T-overhangs. The composition of the ligation reaction was 5 µl of 
water, 1 µl of lOX ligation buffer, 2 µl of resuspended pCR™ Ilvector (25 nglµl), 1 µ1 of 
purified PCR product, and 1 µl of T 4 DNA ligase. The amount (X ng) of PCR product of 
"Y" base pairs ( 505 bp) to be ligated to the vector with a 1 :3 molar ratio was calculated 
according to the equation below: 
3X ng PCR product!Y bp PCR product= SO ng pCR™ Il vector/size in bp of the 
pCR™ vector (3932 bp). 
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The Jigation reaction was incubated at 12°C overnight Three µ1 of TA Ooning ligati.on 
reaction ( containing Jigated recombinant plasmid DNA) were combined with 50 µ1 ONE 
SHOT™ competent cells. After adding 450 µ1 of prewanned SOC medium to the vial, the 
cells were incubated at 3T'C for exactly 1 hr with shaking at 225 ipm in an orbit shaker 
incubator. Twenty five µland 100 µl from the transformation vial were then plated out on 
the LB agar plates containing an anti'biotic ampicillin (50 µglml) and X-gal (25 µ1 of 40 
mg/ml X-gal stock was spread on the plates 1 hr before spreading the cells). After 
incubating at 37°C overnight, the white colonies were lifted and grown in 10 mis of Luria-
Bertani(LB)-ampicillin medium (ampicillin concentration; SO µ.glml) at 3T'C overnight to 
pwify the plasmid. 
The Wizard Miniprep DNA Pwifi.cation System from Promega was used to pwify 
the plasmid. Five-six mis of cells from 10 ml cultures ( 1 ml was saved in 1 volume of LB 
medium containing 30% glycerol for frozen cell stocks) were treated with cell resuspension 
solution, cell lysis solution, then the neutraliz.ation solution and centrifuged to precipitate 
the cell debris. The plasmid in the supernatant was then purified using the Wiz.ard 
Miniprep DNA purification resin and the Wiz.ard minicolumn. The concentration 
of the plasmid was measured by a SHIMADZU spectrophotometer (model: UV 1201). 
The sequences of 505 bp human Rb cDNA was verified by the sequencing using the ABI 
20 
373A Automatic DNA sequencing system. 
The DNA fragment to be used as the probe (505 bp fragment of the human Rb 
cDNA) was removed :from the plasmid by restric1ion enzyme digestion and separated by 
low melting agarose gel electrophoresis. Final pwification of the insert was done using the 
USBioclean. MP kit as descn"bed above. 
Southern Blot Analysis- Intact genomic DNA from medaka must be prepared. 
Several methods were tried to extract the genomic DNA. W"Jrgin et al. (1990) reported 
that conventional DNA extraction procedw'es ut,lizing protease digestion used on fish 
tissues often yielded a predominance of sheared genomic DNA The medaka genomic 
DNA was extracted by the Wirgin et al. (1990) method for Atlantic tomcod with a slight 
modification. Six whole medaka were used to prepare genomic DNA After removing 
viscera, :fins, and scales, the fish were ground to a :fine powder in a mortar and pestle under 
liquid nitrogen. Approximately 100 mg of each sample was placed into 500 µI of 1 N 
NHiOID 0.2% Triton X-100 in a microcentrifuge tube and mixed well with a spatula. This 
homogenate was incubated for 30-60 min at 37°C with periodic agitation to mix solution 
and sample well. One volume of phenol saturated with 0.1 M Tris, pH 8.0 buffer was 
added to each sample and mixed very gently. The samples were microcentrifuged for 6 
min and the upper phase was transferred to a new tube using a pre-cut pipette tip. One 
more phenol extraction was performed. This was followed by two rounds of phenol-
chloroform (1:1) (chloroform with isoamyl alcoho~ 24:1, v:v), chloroform extractions 
(with isoamyl alcoho~ 24:1, v:v). After the final chloroform extraction, the DNA in the 
supernatant was precipitated with 1/lOvolmne of3 M sodium acetate ( pH 7.0) and 2 
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volumes of 100% ethanol overnight at -20°C. DNA was pelleted by microcentrifugation at 
16, 000 x g for 30 min, then washed with 70% ethanol and air dried. The purified 
genomic DNA was dissolved in TE buffer (10 mM Tris, 1 mM EDT A, pH 8.0) at 4°C 
overnight and treated with RNase A to remove RNA. This was followed by one round of 
phenol-chloroform (1:1), chloroform extraction, and ethanol precipit.ation. DNA was 
resuspended in TE buffer. DNA concentration and purity were determined using a 
spectrophotometer. Aliquots of the genomic DNA were electrophoresed on a 0.5% 
agarose gel in order to check the DNA's integrity. 
Human genomic DNA (from Promega) was used as a control. Medaka genomic 
DNA (10-15 µg) and human genomic DNA (10 µg) were digested withHindDI 
(Promega). In the digestion reaction, 1/10 of the total volume of enzyme buffer (30 µl) 
and 30-45 units of the enzyme were added. The digestion was performed at 37°C for 5-6 
hr, then the samples were extracted with phenol:chlorofonn and precipit.ated with ethanol. 
The samples were dissolved in TE buffer, loaded on a 0.8% agarose gel, and 
electrophoresed in a GibcoBRL Horizon 11-14 unit at 40 volts with the lambda DNA-
Hindlll size maker. After electrophoresis, the DNA was transferred to a nylon membrane 
(Zet.a Probe; Biorad) by capiltazy action in 0.4 M NaOH according to the manufacturer's 
instructions. 
The DNA fragment to be used as the probe was prepared as described above under 
the section "Hybridization probe". The probe was labeled with a radioisotope (32P) using a 
Random Primed DNA Labeling Kit (United St.ates Biochemical). The cDNA (25 ng in a 
tot.al volume of 9 µl) was heated at 95°C for 5 min in an eppendorf tube and then chilled 
on ice. The denatured DNA was combined with the following reagents on ice: 3 µl dATP, 
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dGTP, dTTP mixture, 2 µ1 reaction mixture (random hexanucleotide in lOX reaction 
buffer; 2 M Hepes, pH 6.6, 2 mM Tris-HCJ, pH 7, 0.1 mM EDTA, 4 mg/ml bovine serum 
albumin ), 5 µ1 a.-32P dCTP (50 µC~ 3000Ci/mmole, NEN), and 1 µ.t Kienow enzyme 
(2 units). The mixture was incubated at 37°C for 1 hr. The reaction was tenninated by 
adding 2 µ.t of0.2 M EDTA, pH 8. The unincorporated nucleotides were removed by 
ethanol precipitation or by chromatography on Sephadex G-50. The specific activity of the 
probe (2 x id') was measured by DE 81 assay. 
The filter.was hybridized with 2 x 106 cpm/ml of a.-32P-labeled probe. The 
hybridization was performed in 40% deionized fonnamide, 5X SSC (IX SSC: 0.15 M 
NaCl, 0.015 M Na3ci1rate-H20, pH 7), 7% sodium dodecyl sulfate (SOS), 1 % 
polyethylene glycol (PEG) 20,000, 0.5% nonfat dried milk, and 0.3 mg/ml salmon-spemt 
DNA at 42°C overnight. The filter was then washed twice at room temperature for 20 min 
with vigorous agitation in 2X SSC/0.1 % SOS followed by two washes at 60°C for 30 min 
in 0.2X SSC/0.1 % SOS. After evecy wash, radioactivity on the filter was assessed with a 
mini Geiger counter. The filter was autoradiographed to Kodak XAR-5 film at -85°C with 
an intensifying screen. 
Northern Blot Analysis-- For RNA isolation the modified Chomzinsky and Sacchi 
method (1987) was used. Various organs (liver, gastrointestinal tract, eye, gill, brain, 
muscle, skin, and spleen) were dissected out ofmedaka, collected in eppendorftubes on 
dry ice, and stored at-85°C. Some organs (liver, gastrointes1inal tract, and eye) were used 
fresh for RNA isolation. The organs were placed in 500 µ.t of the denaturing solution 
(solution D: 4 M guanidinium thiocyanate, 25 mM sodium citrate, pH 7, 0.5% sarcosyl, 
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0.1 M 2-mercaptoethanol) and immediately homogenized. For RNA isolation from eggs, 
about 200 medaka eggs were ground to a fine powder in a mortar in the presence of liquid 
nitrogen. The ground sample (about 100 mg) was placed in 500 µ1 of denaturing solution 
(solution D) and homogenized. For-:fiy, approximately SO :fiy were homogenized in 500 µ1 
denaturing solution. Sequentially, SO µ1 of 2 M sodium acetate, pH 4, SOO µ1 of phenol 
(water saturated), and 100 µ1 of chlorofonn-isoamyl alcohol mixture (49:1) were added to 
the homogenate, with thorough mixing by inversion after the addition of each reagent. 
The final suspension was vortexed for 10 sec and cooled on ice for 15 min. Samples were 
microcentrifuged at 16,000 x g for 30 min at 4°C. After centrifugation, the aqueous phase 
was transferred to a fresh tube, mixed with 1 volume of isopropanol, and then placed at 
-20°C for 2 hr. Sedimentation at 16,000 x g for 30 min was again performed. The 
resulting RNA pellet was dissolved in 150 µ1 of SQlution D, transferred into a new tube, 
and precipitated with 1 volume ofisopropanol at-20°C for 1 hr. After microcen1rifugation 
for 10 min at 4°C, the RNA pellet was resuspended in 700.4, ethanol. The pellet was 
broken up by repeatedly pipetting it up and down in 70% ethanol. This wash was done at 
least twice. The pellet was dissolved in 75 µ1 of 1 mM EDT A, pH 8, treated with diethyl 
pyrocarbonate (DEP). The solution was precipitated with 1/10 volume of 2 M sodium 
acetate, pH 4, and 2 volumes of ethanol at -20°C overnight. RNA was pelleted by 
microcentrifugation at 16,000 x g for 30 min at 4°C, then washed in 70% ethanol and air 
dried. The RNA pellet was dissolved in DEP- treated H20. The quality of RNA was 
checked by spectrophotometer and the A'NIIA2f/J ratio was 1.7-1.8. The KS62 cell line and 
:frog liver RNA were used for positive controls. Komblau et al (1994) used the KS62 cell 
as a Rb-positive control in their experiment and this cell line expressed Rb protein well. 
The frog (Xenopus) was obtained from Dr. John Band.e's laboratocy at OkJahoma State 
University. 
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Poly (A) RNA isolation was done according to the procedure provided by 
Promega PolyATtract• mRNA isolation system. 500 µ1 of RNA solution (1 mg) were 
placed in a 65°C heating block for 10 min. Three µ1 of the Bio1mylated-Oligo( dT) Probe 
and 13 µ1 of 20X SSC were added to RNA. The solution was mixed gently and incubated 
at room temperature until completely cooled. The Streptavidin-Paramagnetic Particles 
(SA-PMPs) were washed three times with 0.5X SSC using a magnetic stand and 
resuspended in 0.1 ml of0.5X SSC during the incubation time. The entire contents of the 
annealing reaction were added to the tube containing the washed SA-PMPs and the tube 
was incubated at room temperature for 10 min. The supernatant was removed without 
disturbing the SA-PMPs pellet captured by the magnetic stand. The particles were washed 
four times with O.lX SSC by gently flicking the bottom of the tube until all of the particles 
were resuspended. To elute the mRNA, the final SA-PMP pellet was resuspended in 0.1 
ml of the RNase-Free water. The eluted mRNA aqueous phase was transferred to a sterile, 
RNase-free tube. The elution step was repeated with 0.15 ml of the RNase-Free water and 
pooled to the first elution. The AudA2m ratio was > 1.9. 
Total RNA (20 µg) or poly(A)-enriched RNA (3-4 µg; Human K562 cell line 
<lµg) were electrophoresed on a 1.00-4 agarose gel containing 0.67 M fonnaldehyde 
(Davis et al., 1986). RNA was traneferred in 50 mM NaOH to a nylon membrane (Zeta 
Probe; Biorad) by capillary action. 
The radioisotope labeled 505 bp probe was prepared using the same method 
described above for the Southern blot analysis. The filter was hybridized with 3-5 x U>6 
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cpm/ml of the probe. The hybridiz.ation was performed in 500.4> deionized fonnamide, 
7% SDS, 1% PEG 20,000, 2X SSPE (lX SSPE: 0.15 M NaCl, 0.01 M NaHJ>Q4 • H20, 
and 1 mM EDTA), 0.5% nonfat dried milk, and 0.5 mg/ml salmon sperm DNA. Washing 
was the same as for Southern blot analysis as descnbed above. The filter was 
autoradiographed to Kodak XAR-5 film at -85°C with two intensifying screens. 
Western Blot Analysis -- Organs were dissected out of 10 medaka and stored at 
-85°C. One hundred eggs of 1 day or over 6 days after fertilization were collected as 
described in the Materials section above and ground to a fine powder in a mortar under 
liquid nitrogen. Fifty fry were collected and stored at -85°C. The samples were 
homogenized in 150 µ1-250 µ1 of modified EBC buffer (10 mM HEPES, pH 7.4, 4 M 
NaCl, 10 µg/ml aprotinin, 10 µg/ml phenylmethylsulfonyl fluoride, 2 mM EDTA, and 
2 mM EGTA). The homogenates were spun for 20 min in a microcentrifuge at 16,000 x g 
at 4 °C. The supernatants were transferred to new tubes. The protein concentration of the 
extracts was measured usmg the Bio-Rad Protein Assay based on the method of Bradford 
(1976). Bovine serum albumin was used as the standard Proteins were resolved by 
electrophoresis on SDS-P AGE. One volume of each homogenate was combined with at 
least an equal volume of sample buffer (0.125 M Tris, pH 6.8, 4% SDS, 20% glycerol, 
and 10% 2-.B-mercaptoethanol) containing bromophenol blue. Twenty five-thirty µg of 
each sample were electrophoresed on 7.5% SDS polyacrylamide gels at 25 volts for 1.5 hr, 
50 volts for 0.5 hr, 75 volts for 0.5 hr, and 100 volts for 0.5 hr using a mini gel apparatus 
(Bio-Rad Mini protean Il). One gel was stained with coomassie blue and a duplicate gel 
was electroblotted to Immobilon e polyvinylidene difluoride microporous membrane 
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(Millipore, Bedford, MA). The membrane was blocked with blocking buffer (25 mM Tris, 
pH 6.8, 125 mM NaCl, 0.1 % Tween 20, and 4% bovine serum albwnin) for 1 hr at room 
temperature. An1ibody against the.Rb gene product was obtained from Oncogene Sciences 
(Rb Ab-1, # OP28) and was diluted in blocking buffer from the manufactured stock to a 
final concentration of 2.5 µglml The antibody was clone C36 which is a mouse 
monoclonal antibody generated by immunizing BALB/c mice with cellular Rb and fusing 
its spleen cells with NS-1 mouse myeloma cells. This antibody recognizes an epitope 
between amino acid 300-380 of the human Rb protein. The membrane was incubated 
with primary antibody overnight at 4°C and rinsed 3 times for 30 min with PBS (10 mM 
NaiHP04, 0.9% NaCl, pH 7.5). The membrane was incubated with secondary antibody 
(alkaline phosphatase-conjugated affinipme rabbit anti-mouse lgG (H+L)) obtained from 
Jackson hnmwio Research (Westgrove, PA) for 1 hr at room temperature with gentle 
agitation and washed 3 times for 30 min with PBS. The protein bands were visualized by 
addition of 10 mM Tris, pH 9.5, 10 mM NaCl, 10 mM Mg(CiHJ0i)2-4H20, 100 µglml 5-
bromo-4-chloro-3-indolyl-phosphate (BCIP), 1 µglml nitro blue tetrazolium (NBT) and 
development was stopped upon transfer to deionized water. For a negative control, 
Western blot analyses were done without a primary antibody incubation step (Figs. 6B, 7C, 
and 8C). 
Results 
Conservation of Rb Gene in Medaka 
To detect the Rb gene of medaka, a Southern blot analysis of Hind.ID. digested 
genomic DNA from medaka whole tissues was performed by using a 505 bp probe 
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derived from the human Rb cDNA. The amino acids of SOS bp human cDNA :fragment 
corresponded to one of two adenovirus ElA binding sites (amino acids 405-573). Human 
genomic DNA was used as a positive control (Fig. 2A). Digestion of genomic DNA with 
Hindlll resulted in an approximately 4.0 kb segment for medaka compared to a 7.5 kb 
band for human (Fig. 2B). The results of this experiment indicated that medaka genomic 
DNA contained sequences that were sufficiently homologous to be cross-hybridized with 
the human Rb gene probe. 
Detection of the Rb mRNA in Medaka 
Since human Rb cDNA probe could cross-hybridize to medaka Rb gene, detection 
of the Rb transcript was tested by Northern blot analysis in preliminary experiments. As 
shown in Fig. 3A and 3B, the Rb mRNA was detected in medaka liver and viscera. The 
size of the Rb transcript appeared to be about 4. 7 kb which is the same size as expected in 
human. The same result was obtained·with poly (A)-enriched RNA (Fig. 4). The size 
identity of Northern blot band in medaka to that in human and presence of only one band 
suggested that Northern blot band detected by human Rb probe was genuine medaka Rb 
transcript. Furthermore, the hybridization conditions employed in these experiments 
sufficiently high stringency ( 50°C in the presence of 50% fonnamide) which could rule out 
nonspecific binding of human Rb probe. Xenopus RNA which has been known to contain 
Rb mRNA (Destree eta1., 1992) was used as an additional positive control (Fig. 3B). 
Next, I determined which organs in adult medaka expressed Rb gene (Fig. 5 A and 
B). Northern blot analysis was undertaken for the RNA extracted from various medaka 
tissues. The Rb transcript was detected in all the tissues examined (Fig. SB). The level of 
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expression of the Rb gene varied for the different tissues. Even though the level of Rb 
gene expression varied among tissues, liver, gastrointestinal tract, muscle, skin, and spleen 
were found to express relatively high level of Rb gene. 
Detection of the Rb Protein in Medaka 
Western blot analysis was undertaken to detect medaka Rb protein by using 
commercially available monoclonal antibody against human Rb. Rainbow trout liver of 
which Rb could be detected by the same antibody was used as a positive control. The 
antibody recognized a protein with an apparent molecular weight of 97 kDa from medaka 
liver tissue. The 97 kDa protein was thought to be Rb protein based on comigration with 
the positive protein from rainbow trout and lack of 97 kDa band when the primary 
antibody was omitted (Fig. 6A and B). There appeared an additional immunoreactive 
proteins at 66 and 45 kDa from the lysates of both medaka and rainbow trout It remains 
unclear whether these proteins are related to Rb protein. In medaka, a nwnber of other 
bands were detected between 64 and 70 kDa which I considered non-specific proteins 
because of inconsistent detection especially by horse radish peroxidase visualiz.ation method 
(Data not shown). The medaka liver, in addition, had higher molecular weight bands of 
approximately 116 and 160 kDa. These proteins might be highly phosphorylated form of 
Rb. The phosphorylation status of Rb might affect migration mode on SOS-PAGE. 
In order to determine the relative expression of Rb protein in various medaka 
tissues, the same amount of protein was loaded onto the SDS-P AGE gel (Fig. 7 A and B). 
Liver had relatively high levels of Rb protein. The 97, 66, and 45 kDa bands were found 
in liver. Gastrointestinal tract didn't have detectable Rb protein. Eye and gill had a 45 kDa 
band. Brain had the 97, 66, and 45 kDa bands. The 66 kDa was predominant in this 
tissue. Skin and muscle showed approximately 64, 60, and 45 kDa bands, while a 180 
- kDa band was present in muscle. The intensities of 97 kDa band varied among tissues. 
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Detection of 97 kDa protein was confined to specific tissues. The 45 kDa band was 
present in all the tissues examined except for gastrointestinal tract. The identity of 45 k.Da 
protein remained unclear. 
The expression of the Rb protein during early developmental stages was analyzed 
by Western blot analysis (Fig. 8 A and B). In the early (1 day after fertiliz.ation) and late 
egg stages ( over 6 days after fertili7.ation), a polypeptide of molecular weight of 
approximately 105 kDa was found. The 105 kDa protein might be highly phosphorylated 
form which preferentially expressed in highly proliferative cells. However, the 105 kDa 
band was not detected in the fry ·stage when cells become less proliferative. Again, the 
detection of Rb was specifically confined to the certain developmental stages. There were 
additional bands in late egg and fry stages at 80, 64, or 60 k.Da. The 45 kDa band was 
present in both the late egg and fry stages. 
Discussion 
The first objective of my experiments was to detennine whether the human Rb 
cDNA could be used as a probe for medaka Rb. For this end, I earned out a Southern blot 
analysis to detect Rb gene with medaka genomic DNA. I chose a probe from the human 
Rb cDNA from a region which has .been reported to be highly consetved in among species 
(human, mouse, frog, and chicken) (Destree et al., 1992; Feinstein et al., 1994). This 
region covers exon 13-17 of human Rb cDNA which encodes one of two El A binding 
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regions. This human Rb probe with size of 505 bp showed 73% amino acid identity in 
Xenopus (Destree et al., 1992) and 800.4> in chicken (Feinstein et al, 1994). I expected that 
there might be a similar degree of identity with medaka. With this probe I was successfully 
able to detect Rb gene from medaka genomic DNA The probe was verified by 
hybridiz.ation to a 7. 5 kb HindIII :fragment containing human Rb exons 13-17 as expected 
(Hong et al., 1989). This evidence suggests that the Rb gene is present in the medaka. 
The next objective, was to detect the Rb transcript in medaka with this probe by 
Northern blot analysis. Human K562 cell and Xenopus liver total RNA were used as 
positive controls. A message with nearly the same size as the human Rb mRNA 
( approximately 4. 7 kb) was detected in the medaka. There was only one size of transcript 
in the medaka which ruled out alternative splicing. For human, mouse, and chicken, Rb 
transcript has been reported to be present as a size of 4.7/4.5 kb in all tissues except mouse 
testis, where a 2.8 kb RNA was also found (Bernards et al., 1989). However, inXenopus 
two major Rb RNA species (4.2 kb and 10 kb) were found in all tissues and developmental 
stages. The relative ratio between the expression levels of the 4.2 and 10 kb transcripts 
varied significantly for the different tissues (Destree et al., 1992). Xenopus liver RNA was 
used as a positive control. The 10 kb transcript·was not detected in my experiment. This 
was ·not unexpected,· because the 10 kb transcript was barely detectable in X enopus liver in 
original paper (Destree et al., 1992). The nature of these mRNAs with unusual size 
( 2.8 kb and 10 kb) is unknown at present time. InXenopus, it was suggested that the 10 
kb transcript may be either a precursor of the 4.2 kb transcript or alternative splicing 
product (Destree et al., 1992). 
31 
Since the probe selected from the conserved region of human Rb cDNA could 
cross-hybridize with medaka Rb gene, I became interested in Rb expression patterns in the 
various organs of medaka. The RNA extracted from adult medaka were examined for 
expression of the Rb transcript by Northern blot analysis. The 4. 7 kb transcript was 
detected in all the organs examined, even though the level of Rb mRNA varied for the 
different tissues. Relatively high levels of Rb mRNA were detected in liver, gastrointestinal 
tract, muscle, skin and spleen, whereas low levels in brain. For comparison pwpose, an 
exactly same amount of total RNA (20 µg) was loaded on the agarose gel. In some organs 
two major RNA bands, 28S and 18S rRNA, were not intact on the fonnaldehyde gel. 
Therefore, it is possible that the different quality of total RNA in each organ may have 
affected my results. Considering RNA from skin and spleen with blurry 28S and 18S 
rRNA bands showed a relatively higher level of Rb expression compared with that from 
eye and gill containing clear rRNA bands, the quality of RNA may not decisively attribute 
to differential Rb expression in various organs in this experiment. If degradation of total 
RNA was a major contribution to differential levels of Northern blot bands, a streaking of 
bands resulting from degradation of RNA should have been apparent The use of a 
housekeeping gene cDNA probe such as actin cDNA, as a internal control, could have 
confirmed my notion. Alternatively, in situ hybridiz.ation can be used to determine the 
exact spatial Rb expression patterns in tissues. · 
Northern blot analyses showed that the presence of Rb transcript was ubiquitous in 
all the tissues tested of the adult medaka. In order to examine the Rb RNA expression 
levels correlate with the Rb protein levels in medaka, I earned out Western blot analyses 
with a monoclonal antibody against human Rb. The molecular mass of the band detected 
_in adult medaka 1issues by western blot analyses was approximately 97 kDa in size. The 
molecular weight of 110-114 kDa (Lee et al, 1987b), 115 kDa (Yokota et al., 1988) or 
105 kDa (Whyte et al., 1988) Rb protein has been identified mainly by 
innnunoprecipitation approaches using tumor cells and antibodies against a typeE-Rb 
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fusion protein or synthetic peptides deduced from the Rb cDNA sequence. The synthetic 
peptide corresponded to the carboxyl-tenninal 15 residues or internal regions of the 
deduced Rb protein sequence. ··Also, Lee et al. (1987b) reported that a spectrum of sizes of 
Rb between 108 and 128 kDa has been detected from quail, mouse, rat, and monkey. In 
Xenopus, the Rb with 99 kDa was the tmljor species (Destree et al., 1992). The size of 
the Rb protein appeared variable among the organisms. The source of size variation for 
Rb protein detennined by SOS-PAGE might be due to phosphorylation. Rb has been 
known to be phosphoiylated at sites of serine and threonine (Riley et al., 1994). The 
degree of phosphorylation of Rb plays regulatoiy role for Rb function with respect to cell 
proliferation. In addition to the main band, I have also observed faster migrating bands on 
SDS-P AGE that react with the antibody. These bands have not been characterized. The 
faint bands between 60 and 70 kDa seemed to be non-specific binding bands. When the 
protein bands were visualized by peroxidase and DAB detection method, the bands at 68 
and 70 kDa turned out to be nonspecific bands (Data not shown). However, the 66 and 45 
kDa bands were detected by both visualization methods ( a1kaline phosphatase and 
peroxidase). It is possible that 66 and 45 kDa bands might be derived from proteolysis of 
the 97 kDa band. Therefore, three protein bands, 97, 66, and 45 kDa seemed to be either 
Rb or Rb-related proteins. This hypothesis is supported by a recent report (An and Dou, 
1996) that hypophosphoiylated Rb protein was cleaved to two fragments, 68 and 48 kDa 
which are remarkably close to what I have obseived. Proteolytic cleavage of Rb protein 
was implicated to involve in apoptosis (programmed cell death) (An and Dou, 1996). 
Therefore, identification of Rb proteins by Western blot analysis in various tissues would 
provide important information on the role of Rb in medaka. 
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The presence of the Rb protein was tested in various tissues that were used for 
Northern blot analysis. The relative detection levels between Rb transcript and protein 
were not correspondingly relevant in tissues tested. Liver had relatively high level of both 
Rb transcript and protein, whereas brain had high Rb protein but low Rb transcript. Rb 
protein (97 kDa) was weakly detected in muscle, skin, and spleen, even though the 
expression of the Rb transcript was high. In the gastrointestinal tract, Rb protein was not 
detected. Gastrointestinal tract showed vecy faint protein bands in coomassie blue stain 
compared with those of other organs even the same concentration of protein was used. 
Due to high contents of proteases in gastrointestinal tract, proteins in the organ might be 
degraded to small fragments. Therefore, the poor detection of Rb protein in the 
gastrointestinal tract might be due to loss by proteolytic degradation. Although Rb 
transcript was ubiquitously expressed in medaka, the Rb protein was not present in all 
medaka tissues examined. These observations suggest that regulation of the Rb fimction 
may not be at the level of transcription but at translation or post-translational modification, 
such as phosphorylation in medaka. The rate of translation might vary for the different 
tissues. Another possibility is that tum-over rate of Rb protein might be different in each 
tissues. Riley et al. (1994) insisted that since Rb protein is constitutively expressed in 
normal cells, has a half-life of at least 12 hr, and is present in all mammalian cells tested to 
date, regulation of Rb must be accomplished post-translationally. Rb is activated and 
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deactivated at appropriate times during cell cycle mainly through dephosphorylation and 
phosphorylation process. At the same time, apoptosis enhances cleavage of Rb protein by 
interleukin !~-converting enzyme (ICE)-like protease (An and Dou, 1996). Therefore, 
medaka could provide an excellent system by which physiological role of Rb can be 
investigated in embryonic development, cell proliferation, and cell death. 
The levels of Rb protein in early medaka development are shown in Fig. 8. I chose 
three developmental stages used by Kirchen and West (1976) to determine the expression 
of the Rb protein; early egg stage (1 day after fertilization), late egg stage (over 6 days after 
fertiliz.ation, most organs are formed) and fry stage (after hatching). The result showed 
that the 105 kDa band was detected in the egg stages, but not in the fry stage. The similar 
protein banding pattern was obseived using peroxidase and DAB detecting method (Data 
not shown), suggesting that protein bands. detected were all Rb-related. Interestingly in 
early egg stage, only one protein band ( 105 kDa) was detected. Later, several new bands 
appeared as embryonic development progressed to late egg and fry stage. Based on the 
result, I could draw a correlation that at early egg stage 105 kDa Rb was dominant and as 
tissue further developed up to fry stage, 105 kDa became cleaved to smaller fragments. 
This correlation was intriguing because 105 kDa Rb only appeared on the egg stage where 
cell proliferation is highly active; 
One day after fertiliz.ation medaka embryos are in late gastrula or early neurula 
stage (Kirchen and West, 1976). The zygote nucleus nndergoes a series of mitotic 
divisions after fertilization. The resulting daughter nuclei usually become partitioned off in 
separate cells fashioned from the cytoplasm of the zygote. This cleavage stage is followed 
by a morphogenesis stage. During the morphogenesis stage, the many celfa produced by 
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cleavage continue to divide but segregate themselves into distinct layers and masses. 
Although the cells of the embtyo during this phase of development are organized into 
distinct groups, they are all similar in structure. At this early stages, tissues ( or organs) are 
not yet formed and cells have not reached to the point where 1he cell cycles are arrested to 
differentiate. At this high proliferative stage, Rb protein maintained as a 105 kDa in size, 
probably hyperphosphorylated Rb form. The hyperphosphorylated form of Rb, but not 
the hypophosphorylated form, has \)een suggested to involve in cell proliferation by others 
(DeCaprio et al., 1989; Chen et al, 1989). 
In late egg stage ( over 6 days after fertilization), the rudiments of most organs are 
developed by cell differentiation. This is the developmental stage where in addition to 105 
kDa Rb new smaller forms of Rb, probably resulting from proteolytic cleavage, began to 
appear in medaka. Therefore; the timing of cleavage of Rb protein was coincident with the 
developmental stage where cell differentiation or apoptosis might occur. 
All primitive organ systems are represented at fry stage. New smaller 
irnmunoreactive proteins also appeared at fry stage. The significance of these smaller 
proteins in late egg and fry stages remains to be determined at present. It is possible that 
faster migrating bands are due to proteolysis by interleukin 1 ~-converting (ICE)-like 
protease as proposed by An and Dou (1996). Therefore, it is possible that these bands are 
developmental stage-specific proteins. In Xenopus, additional irnmwioreactive bands at 60, 
80, and 180 kDa besides the size of Rb have been detected in early developmental stages. 
Especially, the level of 180 k.Da protein appears to be stage-specific inXenopus. The low 
level of this protein in the unfertilized egg and in stage 3 embryos increased in embryos 
between stage 8 and stage 11.5 (Destree etal., 1992). · In fry stage, 105 kDa band 
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completely disappeared and at the same time low molecular weight proteins appeared. The 
coincident timing of disappearance of the 105 kDa protein and appearance of the small size 
proteins suggested that the 105 kDa protein might be broken down to small fragments in 
this stage by protease. Based on the result, I can establish a hypothesis. The 105 kDa 
(hyperphosphorylated form) protein begin to hypophosphorylate (97 kDa) by phosphatase 
at late egg stage ( apoptotic commitment stage). Then the Rb cleavage enzyme such as an 
ICE-like protease cleaves the newly formed hypophosphorylated Rb to small fragments at 
fry stage ( apoptotic execution stage). Therefore, 105 kDa band disappears and small 
fragments appear at fry stage. 
To date the description of functional biochemistry of Rb protein as a tumor 
suppressor has been delineated considerably. However, it has not been clear whether Rb 
plays an important role in normal embryonic development. Several groups (Lee et al., 
1992; Jacks et al., 1992; Clarke et al., 1992) have reported that Rb is required for normal 
development. To understand the role of Rb in embryonic development they constructed a 
mouse strain in which one allele of Rb is disrupted. Homozygous mutants die between day 
14 and 16 of gestation with multiple defects in neural and haematopoietic development 
while the heterozygous mice appeared normal without developing retinoblastoma. Thus 
Rb is essential for nonnal development. 
An examination of the expression of the retinoblastoma gene and the regulation of 
its protein product in medaka should help us to understand the role of this tumor 
suppressor gene during embryonic development because medaka is the only species in 
which retinoblastoma can be induced by carcinogens. Thus this study could lead us to 
establish an excellent model with medaka for understanding cancer such as retinoblastoma. 
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Figure 1. Schematic representation of the structure of the human Rb protein. 
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Figure 2. Southern blot analysis of llindlll-digested genomic DNA. (A) Human 
genomic DNA (10 µg) and medaka genomic DNA (10-15 µg) were digested 
with Hind.Ill restriction enzyme. DNA was elec1rophoresed on a 0.8% 
agarose gel. Lanes:1, Hind.Ill-digested phage A DNA molecular size marker; 
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2, Human genomic DNA; 3, Medaka genomic DNA. (B) Blot was probed with 
a 505 bp fragment of human Rb"cDNA. Hybridiz.ation was performed as 
described in Materials and Methods. Lanes: 1, Human; 2, Medaka. 
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Figure 3. Detection of the Rb gene in various organisms. (A) RNA was isolate from 
each organism. Total RNA (20 µg) was fractionated on a 1 % formaldehyde 
agarose gel. Position of the 28S and 18S ribosomal RNA are indicated (4.2 
and 1.7 kb). (B) Blot was probed with the 505 hp fragment of the human Rb 
cDNA. Hybridiz.ation was performed as described in Materials and Methods. 
Lanes of (A) and (B):1, Human; 2, Medaka liver; 3, Medaka viscera 4, 
Rainbow trout; 5, Frog. 
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Figure 4. Northern blot analysis of poly (A)-enriched RNA mRNA was isolated from 
each organism and hybri.diution was perfonned as described in Materials and 
Methods. Lanes: 1, Human; 2, Medaka viscera; 3, Medalca liver; 4, Rainbow 
trout. 
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Figure 5. Detection of the Rb mRNA in adult medaka. (A) RNA was isolated from 
organs of adult medaka. Total RNA (20 µg) was frac1ionated on a 
formaldehyde 1 % agarose gel. Position of the 28S and 18S ribosomal RNA 
are indicated (4.2 and 1.7 kb). (B) Blot was probed with the 505 bp :fragment 
of the human Rb cDNA. Lanes: 1, Human K562 cells; 2, Liver; 
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3, Gastrointestinal tract; 4, Eye; 5, Gill; 6, Bram; 7, Muscle; 8, Skin; 9, Spleen. 
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Figure 6. Detection of the Rb protein in medaka. (A) 30 µg of the protein from each 
sample was electrophoresed on 7.5% SDS-PAGE followed by visnalimion 
with anti-Rb antJ.l>ody. Lanes: 1, Molecular weight standards; 2, Rainbow 
1rout; 3, Medaka liver; 4, Medaka eye. (B) Negative control in which samples 
were not incubated with primacy antll>od:y. Lanes: 1, Rainbow trout; 
2, Medaka liver; 3, Medaka eye. 
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Figure 7. Detection of the Rb protein in various organs ofmedaka. (A) 30 µg of 
protein from each organ was electrophoresed on SDS-P AGE and proteins were 
stained with coomassie blue. (B) Membrane was stained with anti-Rb anti.body 
and visualized with alkaline phosphatase. (C) Negative control in which the 
membrane was not incubated with anti-Rb anttoody. Lanes of(A), (B), and 
(C): 1, Liver; 2, Gastrointestinal tract; 3, Eye; 4, Gill; S, Brain; 6, Spleen; 
7, Skin; 8, Muscle. 
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Figure 8. Detection of the Rb protein in the early developmental stages of medaka. 
(A) 30 µg of protein from each sample was electrophoresed on a 7.5% SDS-
p AGE and proteins were stained with coomassie blue. (B) Membrane was 
stained with anti-Rb antibody and visualized with alkaline phosphatase. (C) 
Negative control in which the membrane was not incubated with anti-Rb 
antibody. Lanes of (A), (B),and (C): 1, early egg stage (1 day after 
ferti.liz.ation); 2, late egg stage ( over 6 days after ferti.liz.ation); 3, fiy stage. 
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CHAPTER ID 
CONSTRUCTION AND SCREENING OF A cDNA LIBRARY 
wrrn mRNA FROM MEDAKA UVER 
Introduction 
A candidate for the retmoblastoma suppressor gene (Rb) has been cloned and 
characterized (Friend et al., 1986; Fung et al., 1987; Lee et al., 1987a). The isolation of 
the retmoblastoma gene has allowed a detailed analysis of the nature of the gene loss at a 
molecular level. After the identilication of the :first tumor suppressor gene, Rb, researchers 
have attempted to find new tumor suppressor genes and study their involvement in human 
cancer. 
To date, full-length Rb cDNAs have been sequenced from human, mouse, frog, 
and chicken. Although Rb has been associated with cell cycle control, transcriptional 
control and growth inhibition, its exact functions have not been determined (Feinstein et 
al., 1994). To detennine the evolutionary conservation of the Rb gene and to Wlderstand 
the molecular basis of Rb inactivation and its potential role in other tumors, I wanted to 
isolate and clone the Rb gene from medaka. The retmoblastoma was induced in medaka 
by a chemical carcinogen. A vertebrate model for retmoblastoma could be established 
using medaka. 
Two cDNA libraries were used to screen the medaka's Rb gene; one was made in 
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Lambda ZAPII vector (Stratagene) by Dr. Becky Van Beneden's laboratoty and the other 
was made in Lambda gtll by our laboratory. As detailed below I screened both cDNA 
libraries with several different probes. During these experiments, I attempted to develop 
the medaka Rb cDNA probe using RT-PCR. 
Materials and Methods 
Animals- Medaka (Oryzias latipes) used in this study were obtained from our 
breeding colony at Oklahoma State University. 
Chemicals-A cDNA library was consttucted by Dr. Becky Van Beneden using 
total RNA from medaka liver. The library was made in Lambda ZAPil (Stratagene). The 
1iter of the amplified library was 3.17 x 106 pfu/µl. An aliquot of this library was donated 
by Dr. B. V. Beneden. PolyATtract• mRNA Isolation Systems was from Promega 
(Madison, WI). cDNA Synthesis kit, Lambda gtl 1 /EcoR I I CIAP-Treated Vector kit, 
and Gigapack 9 Il packaging extracts were obtained from S1ratagene (Melville, NY). 
Super-Script Preamplification system for RT-PCR was obtained from GibcoBRL 
(Gaithersburg, :MD). Guanidimn thiocyanate and die1hyl pyrocarbonate (DEP) were from 
Sigma Chemical Company (St Louis, MO). Alpha-(32P) dCTP (3000Ci/mmol) was from 
New England Nuclear (Boston, MA). All other reagents were of analytical grade or 
better. 
Construction of a cDNA librm:y in Lambda gtl 1- a cDNA library was made by 
cDNA Synthesis kit according to the manufacturer's protocol. The brief procedures were: 
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Poly (A) (7 µg) was used to synthesize cDNA using linker primer, random 9 mer-primer, 
and S '-methyl-dCTP to make the first strand. After second-strand synthesis and ligation to 
EcoR I adapters, cDNA was size-fractionated through a Sephactyl S-400 column. The 
:fraction eluted at> 0.5 kb was ligated into i\. gtll vector and packaged with Stratagene's 
Gigapack Il Gold. The resulting library was amplified and used for the screening. All 
buffers for the construction of cDNA library were from the kit. 
· (1) RNA and mRNA Isolation- Total RNA was isolated from 50 adult medaka 
livers by the method of Chonizynsky and Sacchi (1987) as described in Materials and 
Methods of Chapter Il. mRNA was prepared using the PolyATtracte mRNA Isolation 
Systems. The detailed procedures were described in Chapter Il. The A'lflAI A2., ratio of 
mRNAwas "'2.1. From 1 mgoftotalRNA, 8.5 Jtgofpoly(A)-enrichedRNAwas 
obtained. 
(2) Bacteria Strain and Media- E. coli strain Y1088 (Stratagene: e14'(mcrA), 
(lac)U 169, supE, supF, hsdR, metB, trpR, tonA21, proC::TnS (kanr) [pMC9amp'tef], 
Note: pMC9 is pBR322 with lacP inserted.) was used for all manipulation of the i\. gtll 
library. The following media were used for propagatingE. coli and the bacteriophage i\.: 
LB (per liter: 10 g tryptone, 5 g yeast extract, S g NaCl, pH 7 .0), bottom agar (LB plus 15 
g/liter agar with 0.2% maltose-10 mM MgS04), top agarose (LB plus 7 ,I liter agarose), 
and SM buffer (50 mM Tris, pH 7.S, 100 mMNaCI, 10 mMMgS04, and 0.1% gelaun). 
(3) First-Strand cDNA Synthesis- Poly (A) (7 µgin 34 µ1 DEP H20) was added 
to 16 µ1 of the first strand synthesis reaction mixture ( 5µ11 OX first-strand buffer, 3 µ1 first-
strand methyl nucleotide mixture, 2 µ! linker-primer (1.4 µg/µl), 1 µ1 random 9 mer-primer 
(80 DWµl), 1 µl RNase block I (40 U/µl), 0.5 µl a.-32P-labeled dATP (800 Ci/mmol), and 
3.5 µI :MMLV-RT (20 U/µl). The reaction mixture was incubated at 37°C for 1 hr and 
then kept on ice until the second-strand synthesis. 
(4) Second-Strand Synthesis- To 45 µl offirst-s1rand reaction mixture, the 
following reagents were added in order: 20 µ11 OX second-strand buffer, 6 µl second-
strand nucleotide mixture, 106.2 µl sterile distilled water, 2 µl a-32P-labeled dATP (800 
Ci/mmol), 3.S µl RNase H (0.9 U/µl), and 10 µl DNA polymerase I (10 U/µl). The 
mixture was incubated at 16°C for 2.S hr and immediately placed on ice. 
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(5) Blunting the cDNA Tennini- 23 µl of blunting dNTP mix and 2 µl of cloned 
Pfu polymerase were added to the reaction tube. The reaction was incubated at 72°C for 
30 min. The reaction was tenninated by extraction with 200 µl phenol:chlorofonn 
(1 :1 v/v). After extraction with another equal volume of chlorofonn, the cDNA was 
precipitated with 1/10 volume of 3M sodium acetate and 2 volumes of ethanol overnight, 
then washed with 70% ethanol and dried. The pellet was resuspended in 9 µI of EcoR I 
adapters. 
(6) T .igating the EcoR 1 Adapters- The following components were added to the 
tube containing the blunted cDNA and the EcoR I adapters: lµl lOX ligase buffer, 1 µ110 
mM 1ATP, and 1 µI T4 DNA ligase (4U/µl). The reaction mixture was incubated at 8°C 
overnight and the reaction was tenninated by heating at 70°C for 30 min. 
(7) Kinasing the EcoR I Ends- The kinasing of the adapter ends was done by 
adding 1 µl lOX ligase buffer (500 mM Tris-HCl, pH 1.S, 70 mM MgClz, and 10 mM 
dithiothreitol), 2 µ110 mM 1ATP, 6 µI sterile water, and 0.7 µI T4 polynucleotide kinase 
(10 U/µl). The reaction mixture was incubated at 37°C for 30 min. The kinase was 
inactivated by heating at 70°C for 30 min. 
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(8) Xho I digestion- cDNA Syn1hesis kit from S1ratagene was designed for 
UniZAp™ vector. For this vector, Xho I res1riction is needed for 1he orientation of insert 
DNA However, "- gtl 1 vector arms with dephosphmylated EcoR I sites at each end were 
used andXho I digestion was omitted. Tweenty eight µl of Xho I buffer were added to 
adjust salt concentration for subsequent steps and 3 µl of sterile water were substituted for 
Xho I enzyme to adjust the volum of reaction. Five µl of lOX STE ·buffer were added to 
the reaction mixture for Sephacryl S-400 column separation. 
(9) Size Fractionation- The cDNA was loaded onto a Sephacryl S-400 column 
and spun at 400 x g for 2 min. Fractions were collected four tunes. The size of the cDNA 
was checked by running a 1 % agarose gel and visuaUzing using autoradiography. The 
cDNA was quantitated using the ethidium bromide plate assay according to the 
manufacturer's protocol. The frac1ion contained> 0. 5 kb cDNA was used for ligating into 
the vector arms. 
(10) I .igating cDNA into Lambda gtll/EcoR 1/CIAP-treated Vector Anns-- The 
total ligation reaction volume included 1 µl Lambda gtll/EcoR I prepared anns(l µg), 2.5 
µl cDNA (50 nglµl), 0.5 µl lOX ligation buffer, 0.5 µ110 mM yATP, and 0.5 µl T4 ligase 
( 4 U/µl). The ligation mixture was incubated at 12°C overnight. 
(11) Packing-- The cDNA (1 µI ligation reaction) was immediately added to the 
Freeze-Thaw extract, then the Sonic extract was added to the Freeze-Thaw extract 
containing the DNA. The packaging mixture was incubated for 2 hr at room temperature. 
The packaging was ended by adding 500 µ1 SM buffer and 20 µ1 chloroform, and then 
stored at 4°C. 
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(12) Plating and Titering the Primaty cDNA Libraty- The packaged ligation 
product (1 µ1 of 1:1 and 1:10) was mixed with 200 µ1 ofY1088 cells (Aax, = 0.5) and 
incubated at 37°C for 30 min with gentle shaking. The 3 mJs of top agarose (with 15 µ1 of 
0.5 M IPTG and 50 µ1 X-gal of250 rnglml) were added and the bacteria were plated onto 
the LB plates. The plaques were counted after incubating at 37°C for 7-9 hr. 
(13) Amplification of the 11, gtll Libraty-- The packaged mixtme (20 aliquots) 
which contained 50,000 plaque-fonning bacteriophage units (pfu) was mixed with 600 µ1 
of~= 0.5 host cells (Y1088) and incubated at 37°C for 30 min. The 8 mJs of top 
agarose were mixed with each aliquot of infected bacteria, which were then spread onto a 
freshly poured 150 mm plate of bottom agar. The ruuvesting of the bacteriophage was 
done after 6-8 hr incubation at 37°C by overlaying the plate with 10 ml of SM buffer and 
storing it at 4 °C overnight. The recovery of the bacteriophage with 5% chloroform was 
followed by centrifugation. The amplified library was then stored at 4°C with 0.3% 
chloroform. Some aliquots were stored in 7% dimethylsulfoxide (DMSO) at -85°C. The 
remaining of aliquots were stored at 4°C. The titer of the amplified library was checked in 
the same way as for the primary library. 
cDNA Libraty Screening 
(1) Bacterial Strains-- E. coli strain XL I-Blue (Stratagene: recAJ, endAJ, gyrA96, 
hsdR.17, supE44, reL41, lac, [F' proAB, lacqZNv.fl 5, Tn JO (tet'))) was used for the 11, 
ZAPII library screening. E coli strain SOLR™ (Stratagene: el4" (mcrA"), li(mcrCB-
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hsdSMKmrr) 171, sbcC, recB, umuC::Tn 5 (kanr), uvrC, lac, gyrA96, relA.J, endAJ, '}.,R, 
[F' proAB 1acflZAM15 Tn JO] su· (nonsupressing)) was used for plating excised 
phagemids of the 11, ZAPil library. E. coli stain Y1088 was used for the 11, gtl 1 cDNA 
library screening. 
(2) 11. ZAPil cDNA Libraty Screening--The amplified cDNA was plated on 150 
mm LB plates to 50,000 pfu/plate with 600 µl XL 1 Blue cells at~ = 0.5/plate and 8 mis 
of top agarose/plate (Twenty 150 mm plate used to screen 1 x 106 pfu). The plates were 
incubated at 37°C for 6-8 hr. Each individual plate with plaques was covered with a piece 
of labeled nitrocellulose filter for 2 min to transfer DNA. The filters were lifted off, 
denatured by submersion in a 1.5 M NaCI/0.5 M NaOH solution for 2 min, neutralized in 
a 1.5 M NaCI/0.5 M Trs-Ha (pH 8.0) solution for 5 min, and then rinsed in a 0.2 M Tris-
HCl (pH 7.5) solution for 30 sec. The DNA was crosslinked to the membranes using the 
autocrosslink setting on the lN crosslinker (120,000 µJ oflN energy, lN Stratalinker™ 
2400 from Stratagene ). Hybridiz.ation and filter washes were performed using the same 
method· described for Southern blot analysis in Chapter II. The positive plaques were 
identified by exposure to Kodak XAR-5 film. After film development, the putative clones 
were picked from master plates and stored in 1 ml of SM buffer including 20 µl of 
chloroform. The second and third screenings were done the same way as the first 
screening using small plates (100 mm). 
(3) In vivo Excision of the pBluescript Phagemid from the 11, ZAPII Vector- An 
in vivo excision protocol using the ExAssist helper phage with SOLR strain (Stratagene) 
was used to isolate pBluescript phagemid containing the cloned insert from the vector. In a 
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50 ml polycarbonate tube, 200 µ1 of XL 1 Blue ceDs (~ = 1) prepared with 10 mM 
MgS04, 250 µ1 of phage stock from the third screening ( containing > 1 x 105 phage 
particles), and 1 µ1 of the Ex.Assist helper phage(> lx 106 pfu/µ1) were combined and 
incubated at 37°C for 15 min. Three mls of LB broth were added and the mixture was 
incubated for 2-2.5 hr at 37°C with shaking. The in vivo excision was ended by heating 
the mixture at 70°C for 15 min and centrifugation (4000 x g, 15 min). The phagemid 
stock was stored at 4°C. This stock (10 µ1 or 100 µl) was mixed with 200 µ1 of SOLR. ceDs 
(~ = 1) prepared with 10 mM MgS04, incubated at 37°C for 15 min, and plated onto 
100 mm LB-ampicillin plates (50 µg/ml). The plates were incubated at 37°C overnight. 
Colonies appearing on the plate contain the pBluescript double-stranded phagemid with the 
cloned DNA insert. The colony was streaked on a new LB-ampicillin agar plate to 
maintain the pBluescript phagemid. A bacterial glycerol stock for each putative clone was 
prepared and stored at-85°C. Each phagemid contained the positive insert was prepared 
for Southern blot analysis and sequencing using Wizard™ Miniprep DNA Purification 
System (Promega). 
(4) Lambda gtll cDNA Library Screening-- The method for the screening of this 
library was the same as that of the screening ofi ZAPil cDNA. The Y1088 host strain 
was used instead of XL 1 Blue cell. 
(5) The Preparation of Bacteriophage DNA from 71. gtl 1 cDNA Library-
Lambda DNA was pwified with Wizard™ Lambda Preps DNA Purification System 
(Promega). Phage lysate was prepared by adding 500 µ1 of the overnight host cell (Y1088) 
to a microcentrifuge tube containing 20 µ1 of the amplified cDNA library. The tube was 
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incubated at 37°C for 20 min. The infected culture was transferred to 50 mis of prewanned 
LB broth supplemented with 0. 5 ml of 1 M MgS04 and shaken with 200 ipm in an orbit 
environ shaker (Lab Line Instruments Inc.) at 37°C until cell lysis occurred. After lysis, 
500 µl of chloroform were added to the lysate. The lysate was centrifuged at 8,000 x g for 
10 min and the supernatant was transferred to a sterile tube for the lambda DNA 
purification. Forty µl of resuspended nuclease mixture (0.25 mg/ml RNase A, 0.25 mg/ml 
DNase I, 150 mM NaCl, and 500.4> glycerol) were added to 10 mis oflysate. The lysate 
was incubated at 37°C for 15 min. Four mis of phage precipitant (33% polyethylene glycol 
8,000 and 3.3 M NaCl) were added to the tube. The mixture was placed on ice for 30 min 
and centrifuged at 8,000 x g for 10 min. The supernatant was removed and the pellet was 
resuspended in 500 µl of phage buffer (150 mM NaCl, 40 mM Tris-HCl, pH 7.4, and 10 
mM MgS04). The resuspended phage was transferred to a microcentrifuge tube, treated 
with proteinase K, and centrifuged at 12,000 x g for 10 sec. The supernatant was 
transferred to a new tube and 1 ml of purification resin was added. Then lambda DNA 
containing the inserts was purified with a Wu.ard minicolumn. The purified lambda DNA 
was extracted using phenol:chloroform and precipitated with ethanol. The lambda DNA 
(30 µg) was digested with Kpn I and Sac I. The digested sample was separated using 1 % 
agarose gel electrophoresis and then blotted to a nylon membrane. The Southern blot 
analysis was performed in 50% fonnamide, 4X SSPE, 7% SDS, 1 % PEG 20,000, 0.5% 
blotto, and 0.5 mg/ml sahnon sperm DNA. The 11. gtll vector itself was used as a negative 
control. 
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Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
(1) RNA Isolation- The modified Chomzynsky and Sacchi method (1987) was 
used as described in Chapter Il to isolate total RNA from medaka liver. Typical yield was 
0.6-1 µg RNA/mg tissue. The quality of RNA was checked using a spectrophotometer. 
The Au,o/A280 ratio was over 1.9 and the RNA was undegraded as judged by clear 
definition of the 28S and 18S rRNA bands. 
(2) cDNA Synthesis-- The cDNA template for RT-PCR was synthesized from 
RNA by reverse transcription. cDNA synthesis was performed using Super-Script 
Preamplification System (GibcoBRL) according to the manufacturer's protocol using 43°C 
for reverse transcription and I\OAL V reverse transcriptase. Random primers (hexamers 
having all possible nucleotides at each position) that annealed randomly to the RNA 
molecules were used to prime the cDNA synthesis. A reaction mixture, which contained 
everything except for reverse transcriptase, was used as a negative control. As another 
negative controi a sample of the RNA to be used for RT-PCR was digested with RNase. 
Any bands generated would indicate that genomic DNA was present. 
(3) PCR Amplification-The RT-PCR primers were based on the sequence of 
the human Rb cDNA. Human Rb primers were donated by Dr. S.-H. Park at Whitehead 
Institute. The sequence of the primer pairs was as follows: 
5'cATCT AATGGACTTCCAGAG 3' (R 54) and 3'TCAAGATTCTGAGTTGTACT 5' 
(R 32) (corresponding to the human Rb cDNA exon 10 to 16) 
5'cAGCAGTTCGATATCTACTG3' (SH 51) and 3'TATAGAATCAGTCTGAAGAG 5' 
(R34) (corresponding to the human Rb cDNA exon 6 to 10) 
s·cATCTAATGGACTTCCAGAG3' (R 54) and 3'TATAGAATCAGTCTGAAGAG S' 
(R 34) ( corresponding to the human Rb cDNA exon 10). 
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Amplification reactions were prepared in volumes of 15 µl containing IX PCR buffer (10 
mM Tris-HCl (pH 8.3), SO mM KCl, and 0.001 % gelatin), 1 mM MgC12, 1. 7 µM of each 
primer, 3 µl cDNA and 0.75 U of AmpliTaqpolymerase (Perkin-Elmer Cetus). 
Amplification was performed using a Perkin-Ehner Cetus GeneAmp·PCR System 9600; 2 
cycles were performed of2 min at 94°C, 30 sec at SS°C, and 2 min at 72°C. Forty cycles 
were then performed of 1 min at 94°C, 30 sec at 55°C, and 2 min at 72°C. A 30 sec ramp 
time was inserted between 55°C and 72°C, and 72°C and 94°C. A 1 min ramp was 
inserted between 94°C and 5S°C. The samples were subjected to a 10 min final extension 
at 72°C at the end ·of 40 cycles. After the amplification was complete, 5-10 µl of the 
reaction mixture were analyzed on a 1 % agarose gel. 123-bp and 1 kb DNA ladders 
(Bethsda Research Laboratories) were used as size standards. 
(4) Hybridizations to p3.8 Rb in pUC 13 and/orp0.9 Rb in Sp 65-The RT-PCR 
:fragments were labeled with PCR using 50 µCi cx.-32p-dcTP and used as probes. One µg 
of p3.8 Rb in pUC 13 plasmid digested with EcoR I was loaded on a 1 % agarose gel, 
electrophoresed, and transferred to a nylon membrane (Zeta Probe; Bio-Rad). 
Hybridization was performed at 42°C overnight in 6X SSC, 10 mM EDT A, SX 
Denhardt's solution, 0.5% SDS, 100 µglml denatured salmon spenn DNA, 10% dex1ran 
sulphate, and 50% formamide. The filter was washed twice with 0.2X SSC/0.1 % SOS at 
42°C for 15 min, then twice with O.lX SSC/0.1% SOS at 65°C for 15 min and exposed to 
Kodak XAR -5 film for 1-2 days at -85°C with an intensifying screen. 
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(5) Southern Blot Analysis with Medalca Genomic DNA - Genomic DNA was 
extracted from whole medaka as described in Chapter II and digested with HindilI or 
EcoR I restriction enzymes. The RT-PCR fragments were used as probes. Hybridiution 
was perfonned in 4()0A, fonnamide, 6X SSC, SX Denhardt's solution, 0.1 mg/ml salmon 
spenn DNA, 0.5% SDS, and 0.1 M phosphate buffer, pH 7.0 at 42°C overnight 
Results 
Construction of medaka cDNA library 
RNA and mRNA were isolated from medaka liver to construct a cDNA library. 
Before making the cDNA library, the quality of the RNA and mRNA was analyzed by 
fonnaldehyde agarose gel electrophoresis and the existence of Rb transcript was checked 
by Northern blot analysis (Fig. 9 A and B). TotalRNA and mRNA had a 4. 7 kb of Rb 
transcript. The cDNAlibrary of the medaka was constructed with 7 µg of poly (A) using 
cDNA Synthesis and Lambda gtll/EcoR I/CIAP-treated Vector Kit from Stratagene. The 
primacy phage library (from 1/5 of ligation) packaged was about 0.8 x Hf p:fu/µg of the 
vector. It is usually desirable to amplify h"braries in lambda vectors to make a latge, stable 
quantity of a high-titer stock of the library. To amplify 1 x 106 plaques, two primacy 
phage library packaged were combined and used. The total titer for the amplified phage 
library was 1. 7 x 1 cf pfu/ ml. 
The Screening of Two cDNA libraries 
Two cDNA libraries were screened; one was made in A ZAPII using RNA from 
medaka liver by Dr. B. Van. Beneden and the other was made in :>i.. gtl 1 by me. The 
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libraries were screened with human a 505 bp Rb cDNA as a probe. 
(1) The Screening oft.. ZAPII cDNA Ltbraty 
In the primary screening of the "' ZAPII cDNA hbracy, 27 putative clones were 
detected. Following the second screening, a background problem arose. Some of the 
plaques were expected to show positive signals in the second screening. However, almost 
all plaques appeared to hybridize with the probe (the intensity of the signal varied). In the 
primary screening, the amp1ified cDNA was plated on 150 mm LB plate to 50,000 
pfu/plate. The sizes of plaques in the primary screening are tiny and plaques are so 
confluent compared with that of the second screening. Therefore the background problem 
might not be detected in the primary screening. The plaques which had a stronger signal, 
compared to the other plaques, were chosen as putative clones. In the second screening, 
these positive plaques were too spatially close to the background plaques. The positive 
plaques were contaminated with non-positive plaques (background plaques) when they 
were picked. Thus, a tertiary screening was performed to obtain isolates. The same 
problem occurred in the tertiary screening. All plaques showed positive signals. Finally, 
16 putative clones which had the strongest signal were chosen. 
In vivo excision was performed on the isolates to obtain the insert-containing 
pBluescript phagemid for Southern blot analysis and sequencing. The Southern blot 
analysis was performed to check if the putative clones contained the Rb gene. Each 
phagemid was digested with EcoR I restriction enzyme and electrophoresed on agarose gel 
(Fig. 10). The hybridization was performed with human 505 bp Rb cDNA. The result of 
this experiment (Fig. 11) showed that pBluescript phagemids were crosshybridized with the 
probe. Therefore, the problem in the screening was due to the hybridiz.ation of the 
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phagemid to the probe. The other signals seemed to be from the widigested plasmids, not 
from inserts. Taken together, the :final 16 clones selected from the tertiary screening did 
not contain Rb cDNA. 
(2) The Screening of 11, gtl 1 cDNA library 
The lambda gtl 1 library was screened using the same method as for the A ZAPII 
cDNA library. The result was the same as that of the 11, ZAPII cDNA library. The same 
backgrowid problem occurred in the 11, gtl 1 cDNA library. While the library was being 
screened, a Southern blot analysis was perfonned to check if the cDNA library included 
the Rb cDNA insert. Lambda gtl 1 DNA containing inserts were isolated using the 
Wizard ™ Lambda Preps DNA Purification System and digested with Kpn I and Sac I 
(Fig. 12A). The Southern blot analysis was done using human 505 bp Rb cDNA as a 
probe. The 11. gtl l which did not contain inserts was used as a negative control. The result 
is shown in Fig. 12 B. The probe hybridized to one of the bands from the DNA 
containing inserts (4.3 kb in size). Unfortunately, the same hybridization signal was 
present in the negative control. Therefore, the vector crosshybridized with the probe, not 
with any inserts. Similar to the "' ZAPII cDNA library, the backgrowid problem in this 
screening was due to the vector. 
Development ofMedaka Rb cDNA from RNA Using RT-PCR 
Three fragments were obtained from RT-PCR and their identity was verified by 
hybridization experiments. 
(1) Hybridization to the human Rb cDNA 
To determine if the RT-PCR fragments were medaka Rb cDNA, the fragments 
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were labeled with 32P and used as probes. The fragment produced by the primers RS4 and 
R32 (corresponding to the human Rb cDNA exons 10-16) and the fragment made by the 
primers R54 and R34 (corresponding to exon 10) cross-hybridized to the human 3.8 kb Rb 
cDNA (containing exons 9-27) (Fig. 13 A and B). The fragment made by the primers 
SH51 and R34 (corresponding to the human Rb cDNA exons 6-10) crosshybridized to 
both human 0.9 (exons 1-9) and 3.8 (exons 9-27) kb Rb cDNA (Figs. 13C and 14A). 
(2) Southern Blot Analysis with Medaka Genomic DNA 
Further evidence attesting to the fidelity of RT-PCR fragments was obtained with a 
Southern blot analysis using the fragments as probes. With the medaka genomic DNA 
digested with EcoR I or HindIII, one hybridiution signal was shown in each enzyme 
digested DNA with the 469 bp fragment probe made by R54and R32 primers. The size of 
each signal was 7 and 9.4 kb, respectively (Fig. 15). With the 493 bp fragment made by 
SH5 land R32 primers, 2 signals in EcoR I digested DNA and 3 signals in HindIIl. digested 
DNA were obtained. The sizes of the signals were 13 and 3.8 kb in EcoR I and 5.2, 3. 7, 
and 1.8 kb in HindIII, respectively (Fig. 16). The 349 fragment probe made by R54 and 
R34 primers didn't hybridize to medaka genomic DNA. 
Discussion 
Initially, .11, ZAPil cDNA libraiy was screened using several methods and probes. A 
time-saving method for screening cDNA published by Bloem and Yu (1990) was used. A 
replica of the plate made by lifting a nitrocellulose filter was placed plaque site up in a 
sterile petri-dish and rinsed with lambda dilution buffer. An aliquot of20 µ1 was removed 
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:from each filter rinse, and then used as the template for PCR Human Rb primers were 
used for PCR. The advantage· of this method was to reduction of the library's complexity 
by several orders of magnitude with only one and two rounds of PCR before any filter 
hybridization. A DNA band of the appropriate size was found in 1he primary screening, 
but this turned out to be a non-specific band in the second screening. This method was 
tried 4-5 times with various human Rb primers (Rb #1, Rb #2, Rb #5, SHS1, R34, RS4, 
and R32) . Unfortunately, the expected bands produced by the human primers were not 
found using this method. It seemed that 1he human Rb primers used did not have enough 
sequence homology with medaka DNA. 
Another method for screening cDNA library was immunological screening using 
human Rb antibody. Commercial monoclonal antibodies developed against synthetic 
peptides representing a distinct region of the human Rb were used for Western blot 
analysis with medaka in our laboratory. The experiments were successful with these 
antibodies (Mh-Rb-02Pl :from Pharmingen and Rb Ab-1 :from Oncogene Sciences). 
Screening with the antibodies was unsuccessful. In the Western blot, protein is the primary 
structure. Therefore, it might be easy to detect Rb product. Protein produced in 
bacteriophage is folded. This structure can make it difficult to find the Rb product with 
monoclonal antibody in the screening. The commercial antibodies were expensive. Thus, 
antibodies for screening were limited. 0ur· own Rb polyclonal antt"bodies developed :from 
medaka could be used for screening cDNA library. 
The third method for screening the cDNA library was using radioisotope labeled 
nucleotide probe. The human 3.8 kb Rb cDNA andXenopus Rb cDNA were used as 
probes for screening. Both :fragments did not detect positive plaques. Specifically, 
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Xenopus Rb cDNA showed background problem. From the second screening, all_plaques 
showed hybridization signals ( only some of the plaques were expected to hybridize with 
probe). In the 1'. ZAPil cDNA library, the cDNA was inserted into multiple cloning sites of 
pBluescript phagemid. Xenopus Rb cDNA was subcloned into pBluscript SK. It is 
posstble that the probe was contaminated with the vector, even though the insert used as 
probe was isolated from vector after digestion with the restriction enzyme. To check the 
purity of the XR.b probe, Southern blot analysis was performed. Hwnan 3.8 kb Rb in pUC 
13, 1.2 kb Rb in pCRil, and 0.9 kb Rb in Sp 65 were digested with EcoR l These 
fragments were tested to cross-hybridize with the XR.b probe. The results showed that all 
vectors and 3.8 kb Rb and 1.2 kb Rb strongly hybridized with the probe (data not shown). 
XR.b insert was purified three times to obtain a pure probe, but the resuh was poor again. 
The backbone of the pBluscript and the pCRil vectors is pUC plasmid. From these 
results, it was hypothesized thatXenopus Rb cDNA has sequence homology with the 
vector. 
In preliminary experimen1s to find the Rb gene and Rb 1ranscript, the hwnan 3.8 kb 
Rb cDNA and Xenopus Rb cDNA did not detect them in medaka. Therefore, I tried to 
develop medaka Rb cDNA using RT-PCR in collaboration with Dr. Andrea Fekete. 
The RT-PCR is highly sensitive method that can be used for amplification ofvery low 
levels of specific mRNA. Only a small amount of RNA is required and it is not necessary 
to further isolate poly (A) RNA However, the use of high quality RNA is critical for the 
successful RT-PCR analysis. The quality of RNA used in the experimen1s was checked by 
spectrophotometer and electrophoresis. The amplification reactions were done using 
primers based on the human Rb cDNA We guessed that there would be sequence 
homology to be able to amplify medaka cDNA fragments. Several fragments were 
obtained with RT-PCR and tested for back cross-hybridization to human Rb cDNA. 
Human 3.8 kb Rb in pUC 13 was digested with EcoR I to separate the insert from the 
vector and used for the experiments. As shown in figure 13, the fragments made by RT-
PCR were specifically hybridized to human 3.8 kb Rb cDNA The fidelity of these 
hybridii.ations was obtained :from the experiment using the fragment made by primers 
Rb#l and Rb#2. 0.9 kb Rb in Sp 65 was used as a con1rol. The fragment made by 
primers SHSI and R34 (corresponding to the human Rb cDNA exons 6-10) was 
crosshybridized to both human 0.9 kb (exon 1-9) and 3.8 kb (exons 9-27) Rb cDNA as 
expected (Fig. 14A). However, the fragment made by primers Rb#l and Rb#2 
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( corresponding to the human Rb cDNA exons .1 ~3) was only cross-hybridized to the 0.9 kb 
Rb cDNA (Fig. 14B). 
Southern blot analyses were performed with these fragments as probes to verify 
that they were the Rb cDNA. The results of these experiments indicated that medaka 
genomic DNA contains sequences that crosshybridize with 469 bp (made by RS4 and R32 
primers) and 493 bp :fragment (made by SHSl and R34 primers) probes, but not with the 
349 hp fragment (made by RS4 and R34) probe. As a control, human genomic DNA was 
used. Only one hybridiution signal was shown with the 469 fragment probe. The signal 
was very weak ( data not shown). In Southern blot analysis of Hindlll-digested human 
genomic DNA, 6 of the HindlII res1riction fragments (9.8, 7.5, 6.2, S.3, 4.5 and 2.1 kb) 
were detectable with the 3.8 kb Rb cDNA probe. It was expected that the signal from 
human genomic DNA with the 469 bp fragment probe has the same size with one of 6 
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hybridization bands. Unfortunately, it did not match with any of the 6 signals. Also, RT-
PCR fragment probes did not detect Rb transcript in Northern blot analysis. Therefore, It 
could not be detennined if the fragments made by RT-PCR front medaka are real Rb 
genes. To be certain, the medaka Rb gene should be cloned, sequenced, and then 
compared with the fragments by RT-PCR. 
The screening of the cDNA library was performed with the probe (human SOS bp 
Rb cDNA) made from the conserved A region. As shown in Fig. 11, pBluscript vector 
hybridized to this probe. The same experiment was done with an oligonucleotide probe 
made from the conserved B region. The probe was again hybridized with vector ( data not 
shown). The sequence homology of probe to pBluscript was searched using Mac Vector 
4.1.4. The probes did not show significant sequence hontology to the vector .. 
A new cDNA h"brary was constructed in the lambda gtl 1 vector. The h"brary was 
screened with human SOS bp Rb cDNA. At the same time, lambda phage DNA which 
included the cDNA inserts was isolated and Southern blot analysis was performed to check 
for the presence of the Rb gene in the library. Both showed negative results. The same 
background problem of plaques in i ZAPil occurred in the newly constructed library. In 
Southern blot analysis, lambda phage including inserts and the vector itself were digested 
with res1riction enzymes and probed with human SOS bp Rb cDNA. The probe hybridized 
to the same fragments in both samples. This means the probe hybridized with the vector. 
Different hybridization conditions were used for the screening. The same result was 
obtained. This background problem has existed in all screening experiments and is 
unsolved at this time. Recently, a genomic DNA library has been screened and one 
positive clone was isolated in our laboratory. The clone is being sequenced. If this clone 
turns out to be a Rb fragment, the cDNA library can be screened using this fragment. 
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Figure 9. Northern blot analysis with mRNA and total RNA of medaka. RNA and 
mRNA were isolated :from medaka liver and viscera to construct a cDNA 
library. Before making cDNA library, the quality of the RNA and mRNA was 
analyzed by formaldehyde agarose electrophoresis (A) and the existence of Rb 
transcript was checked by Northern blot analysis (B). Lanes of (A) and (B): 1, 
mRNA ( 4 µg); 2, Human K562 cell (20 µg of total RNA); 3 Medaka liver ( 20 
µg of total RNA); 4, Medaka viscera (20 µg of total RNA). 
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Figure 10. Elec1rophoresis of phagemids from the pu~tive clones. In vivo excision was 
performed on the isolates to obtain the insert-containing pBluescript phagemid 
from the putative clones. Each phagemid was digested with EcoR I restriction 
enzyme and electrophoresed on agarose gel. Lanes: 1-16, Positive clone 
1-16. p indicates pBluescriptvector. 
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Figure 11. Southern blot analysis with phagemids from the positive clones. The 
hybridiz.ation was performed with hwnan SOS bp Rb cDNA as described in 
Materials and Methods. Lanes:1-16, Positive clones 1-16. p indicates pBlue-
script vector. 
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Figure 12. Southern blot analysis with A gtl 1 DNA containing inserts. Lambda gtl 1 
DNA containing inserts were isolated using the Wizard Lambda Preps DNA 
Purification System and digested with Kpn I and Sac I (A). Lanes: 1, 1 kb 
DNA ladder; 2, A gtl 1 vector; 3, A gtl 1 DNA containing inserts. The 
South.em blot analysis was done using human 505 bp Rb cDNA as a probe 
(B). Lanes: 1, A gtl 1 vector; 2, A gtl 1 DNA containing inserts. 
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Figure 13. Crosshybridization ofRT-PCR fragments to human 3.8 kb Rb cDNA. The 
fragment made by primers R54 and R32 (A), the fragment made by primers 
R54 and R34 (B), and the fragmentmade by primers SH51 and R34 (C) were 
crosshybridized to the hmnan 3.8 kb Rb cDNA. 
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Figure 14. Crosshybridiz.ation ofRT-PCR fragments to human 3.8 kb and/or 0.9 kb 
Rb cDNA. The fragment made by primers SHSl and R34 (corresponding to 
the human Rb cDNA exons 6-lO)(A) crosshybridized to both human 0.9 kb 
and 3.8 kb Rb cDNA. However, the fragment made by primers Rb#l and Rb 
#2 ( corresponding to the human Rb cDNA exons 1-3) (B) was only cross-
hybridized to the 0.9 kb Rb cDNA. 
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Figure 15. Southern blot analysis using the 469 bp fragment (made by R54 and R32 
primers) as a probe. In the medaka genomic DNA digested with EcoR I (Lane 
1) or HindllJ. (Lane 2), one hybridization signal was shown in each enzyme. 
The size of each signal was 1 and 9.4 kb, respectively. 
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Figure 16. Southern blot analysis using the 493 bp fragment (made by SH51 and R34 
primers) as a probe. In the medaka genomic DNA digested with restriction 
enzymes, 2 signals in EcoR I digested DNA (Lane 1) and 3 signals in HindIII 
digested DNA (Lane 2) were obtained. The sizes of the signals were 13 and 
3.8 kb in EcoR I and 5.2, 3. 7, and 1.8 kb in HindIII, respectively. 
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CHAPTER IV 
11IE EFFECT OF GROWI'H FACTORS AND HORMONES 
ON MEDAKA Rb PROTEIN 
Introduction 
In nonnal cells, the Rb protein is expressed throughout the cell cycle but its 
functionally active states are ~ed by the degree of phosphorylation (DeCaprio et al., 
1989; Chen et al., 1989; Ludlow et al., 1990). The unphospholylated Rb fonns are 
present in G0 and G1• These fonns seem to be mvolved in preventing the cell front under 
going transition front G1 to S; Whereas the more highly phosphm:ylated fonns are found 
during S and Gi/M phases. The progressive phosphorylation of the Rb protein seemingly 
relieves the block and allows con1inuation of the cell cycle. It has been reported that 
TGF-P (Transforming growth factor P) and IFNa. (Interferon-a.) can affect the 
phosphorylation of the Rb protein (Laiho et al., 1990; Thomas et al., 1991). 
Laiho et al. (1990) showed that addition of the TGF-Pl to mink lung epithelial 
cells (MvlLu) in mid to late G1 prevents phosphorylation of Rb scheduled for this cell 
cycle stage and arrests cells in late G1. When TGF-Pl was added to cells in late G1 or S 
phase, it did not prevent pRb phosphorylation at this stage of the cell cycle. In MvlLu 
ceDs, TGF-fH inhibits cellular proliferation through its ability to downregulate the ac1ivity 
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of the cyclin-dependent kinases cdk2 and cdk4 (Ewen et al., 1993; Koff et al., 1993). 
Ewen et al. (1993) showed that TGF-P inactivates cdk4 by decreasing the level of cdk4 
expression and constitutive expression of cdk4 renders MvlLu cells unresponsive to the 
effects ofTGF-p. Koff et al. (1993) reported that TGF-P does not affect the levels of 
cdk2 expression but downregulates cdk2 activity by recruitmg p27, a protein that is able to 
bind and inactivate cyclin E-cdk2 complexes. In 1994, Kim etal. reported that TGF-P and 
/or epidermal growth factor (EGF) stimulate by three to six-fold the level of Rb mRNA 
which is also reflected by the increased levels of pl lORb in C3H/10Tl/2 mouse 
fibroblasts. Hyperphosphmylation of pl lORb by TGF-P can be observed when cells are in 
S phase. TGF-P stimulates by three to four-fold the activity of cdk2 kinase consistent with 
the observed phosphoiylation of pllORb. TGF-P as a growth stimulator induces the 
phosphorylation of pl 1 ORb during cell cycle progression in mouse fibroblasts (Kim et al., 
1994). Based on the results from Lahio et al. and Kim et al. it seems that the effect of 
TGF-P on cell growth is cell-type specific. 
Other researchers reported that some growth factors affect the level of expression 
of Rb transcript and/or Rb protein (Day et al., 1993; Kim et al., 1994). Day et al. (1993) 
reported that the nerve growth factor inducible A gene (NGFI-A) in human prostate cancer 
cell line binds an element in the retinoblastoma gene promotor and that a 1.9-fold increase 
in Rb mRNA following castration that parallels a 2.7-fold induction ofNGFI-A mRNA in 
gene expression studies of the rat ventral prostate. Based on these results, they suggested 
that the Rb gene may be transcriptionally regulated by NGFI-A in prostate cells. 
Interferon-a. (IFN-a.) is a peptide hormone that regulate the physiology of a variety 
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of cell type (reviewed by Wang et al., 1994). Thomas et al. (1991) demonstrated that 
INF-a. shows a growth-suppressing ac1ivity and leads to a cell cycle block in G 1 in human 
Burkitt lymphoma cells Daudi. Cycling Daudi cells contain mainly hyperphosphorylated 
Rb. When the cells are exposed to IFN-a. for 10 hr, unphosphorylated Rb becomes 
detectable. After exposure for 48 hr, all the Rb is the unphosphorylated fonn. Thus, 
IFN-a. induces the complete dephosphorylation in this cell. 
Rb transcript in medaka is the same size ( 4. 7 kb) as in the human Rb. This is 
detected in all tissues examined in medaka as like mouse. Rb protein is also detected in 
various medaka tissues. It is possible that medaka Rb protein has a similar characteristic 
with that of mammalian Rb protein. Functionally active states of Rb protein are decided by 
the degree of phosphorylation. Growth factors and honnones can affect the 
phosphorylation of the Rb protein as mentioned above. The medaka is an excellent model 
to study retinoblastoma based on the reasons descnbed in Chapter I. In order to study the 
potential effect of growth factors and hormones on the medaka Rb protein, primary tissue 
cultures from medaka liver were treated with EGF, TGF-fH, insulin, or estradiol. 
Materials and Methods 
Animals--Medaka (Otyzias latipes) used in this study were obtained :from our 
breeding colony at Oklahoma State University. 
Chemicals--Antlbody(Rb Ab-1, Cat# OP28) was obtained :from Oncogene Science 
(Cambridge, MA). Biotinylated horse antimouse antibody and peroxidase-conjugated 
avidin-biotin complex (ABC Elite Kit) were :from Vector Laboratories (Burlingame, CA). 
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3,3 '-Diaminobenzidme tetrahydrochloride, TGF-JH, insulin, and estradiol were from 
Sigma Chemical Co. (St. Louis, MO). EGF was obtained from GibcoBRL (Gaithersburg, 
:MD). All other reagents were of analytical grade or better. 
Western Blot Analvsis--Primazy cell cultures of medaka liver were prepared by 
Dr. YuAn Cao. Forty livers were dissected out of medaka and 8 livers were used for each 
treatment and a control. The primary cells were maintained in serum free media for 
1 week to obtain culture growth. Cells were treated with growth factors or hormones for 
1 day at the following concentrations: 100 nglml of EGF in 50 mM sodium phosphate, pH 
7.2, 250 pM/1 of TGF-rn in 4 mM HCl containing 0.1 % bovine serum albumin (BSA), 
1 ff 7 Mil of insulin in 10 mM HC~ or 1 ff 7 Mil estradiol in ethanol. The samples were 
homogenized in 150 µl of modified EBC buffer (10 mM hepes, pH 7.4, 4 M NaC~ 
10 µg/ ml aprotinin, 10 µg/ml phenyhnethylsulfonyl fluoride, 2 mM EDT A, and 2 mM 
EGTA). The homogenates were spun for 20 min in a microcentrifuge at 4°C. The 
supematants were transferred to new tubes. The protein concentration of the extracts was 
measured using the Bio-Rad Protein Assay based on the method of Bradford (1976). 
Bovine serum albumin was used as the standard. Proteins were resolved by electrophoresis 
on SDS-P AGE. One volume of each homogenate was combined with at least an equal 
volume of sample buffer (0.125 M Tris, pH 6.8, 4% SDS, 20% glycero~ and 10% 2-~-
mercaptoethanol) containing bromophenol blue. Thirty µg of each sample were 
electrophoresed on 7.5% SDS polyacrylamide gels at 25 volts for 1. 5 hr, 50 volts for 
0.5 hr, 75 volts for 0.5 hr, and 100 volts for 0.5 hr using a mini gel apparatus (Bio-Rad 
Mini Protean II). One gel was stained with coomassie blue and a duplicated gel was 
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electroblotted to Immobilon polyvinylidene difluoride microporous membrane (Millipore, 
Bedford, MA). The membrane was blocked with Blocking buffer (25 mM Tris, pH 6.8, 
125 mM NaCl, 0.1% Tween 20, and 4% bovine serum albwnin) for 1 hr at room 
temperature. Antibody against the Rb gene product (Rb Ab-1) was diluted in blocking 
buffer to a final concentration of 2.5 µg/ml. The membrane was incubated with primary 
antibody overnight at 4°C and rinsed 3 times for 15 min with TfBS (25 mM Tris, pH 8.0, 
125 mM NaCl, and 0.025% Tween 20). The membrane was incubated with biotmylated 
secondary antibody for 30 min at room temperature, washed 3 times for 15 min with 
TTBS, then incubated with avidine and bio1iny1ated peroxidase complex (ABC Elite Kit) 
for 30 min at room temperature. The protein bands were visualized with 3,3 ' -
diaminobenzidine tetrahydrochloride (DAB) for 45 sec. 
Results 
To investigate the effect of growth factors and honnones in .the expression of Rb 
protein in medaka, primary tissue cultures from medaka liver were treated with EGF, 
TGF-(H, insulin, or estradiol (Fig. 17). The protein band pattern of each sample was 
shown in Fig. 17 A. The 97 kDa band was faint in all samples. The approximately 
66 kDa protein was highly expressed in all samples compared with the 97 kDa band. The 
result indicated that growth factors and honnones did not affect the level of expression of 
Rb protein in medaka (Fig. 17B). 
Discussion 
Some growth factors and honnones affect the phosphorylation and the expression 
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of Rb protein in mammalian cell cultures as mentioned in the introduction of this chapter. 
I expected the involvement of growth factors and hormones in medaka Rb protein to be as 
the mammalian systems. However, the result showed no change in medaka Rb protein 
after treatment with growth factors or hormones. In Western blot, the Rb protein of 
medaka and rainbow trout did not show multiple banding pattern on the SDS-P AGE. It is 
possible that the Western blot analysis in my experiment is not sensitive enough to detect 
the different phosphorylated forms or that the Rb protein of medaka exists as 
homogeneous forms. 
Various growth factors have been found in fishes. For example, insulin like growth 
factor (IGF) was cloned in chum salmon and this has high sequence homology with a 
mammalian gene in the coding region (Moriama et al., 1993). A second IGF was 
identified in rainbow trout (Shamblott et al., 1992). Growth factors (fibroblast growth 
factor and insulin-like growth factor) have been shown to stimulate cell proliferation in 
fishes (Negish et al., 1993; Mack et al., 1993). Even the growth factors found in 
mammalian species have their origins in fishes evolutionarily, the growth factors I used , 
which are human recombinant, might not function in medaka. They might be species-
speci:fic. The receptors can not be existed in tne medaka. The experiment can be tried with 
growth factors prepared from fishes. 
Fish are cold blooded animals and their metabolism might be slower than that of 
mammalian. Thus, a longer incubation ti.me with growth factors and hormones might.be 
needed for fish. My experiment with growth factors and hormones was preliminary work. 
The treatment concentrations were based on papers by Lahio et al. (1990) and Segner et al. 
(1994). A single concentration was used for each treatment. Cells were incubated with 
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treatments for 1 day. Experiments with various concentrations and incubation 1imes might 
be needed to find out for optimal condition for medab. 
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Figure 17. The effect of growth factors or hormones on the medaka Rb protein. The 
primaty tissue cultures of medaka liver were grown for 1 wk in serum free 
media. Cells were incubated with 100 nglml ofEGF, 250 p:M/1 ofTGF-Pl, 
1 ff 7 Mil of insulin, or 1 ff 7 :Mil of estradiol for 24 hr. Cells were lysed and 
lysates were analyzed by Western blot analysis with anti-Rb antibody. Lanes 
of (A) and (B): 1, standard molecular weight marker; 2, Rainbow trout liver; 
3, Control (no treatment); 4, EGF; 5, TGF-in; 6, Insulin; 7, Estradiol. 
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CHAPTERV 
SUMMARY 
To detennine if medaka have the Rb gene, a Southern blot analysis was performed 
on DNA from whole medaka tissues using a 505 bp probe derived from the Human Rb 
cDNA. Medaka genomic DNA contained sequences that crosshybridized with the human 
Rb gene probe. Digestion with Hindill resulted in approximately 4.0 kb segment 
compared with 7 .5 kb for the human. 
Expression of the Rb message in medaka was verified by Northern blot analysis in 
preliminary experiments. The Rb transcript was detected in medaka liver and viscera. The 
size of the Rb transcript appears to be 4. 7 kb in medaka tissues which is the same as that of 
human. The same result was obtained with poly (A)-enriched RNA. I determined which 
organs in adult medaka expressed Rb gene. Northern blot analysis was undertaken for the 
RNA extracted from various medaka tissues. The Rb transcript was detected in all the 
tissues examined. The level of expression of the Rb gene varied for the different tissues. 
Liver, gastrointestinal tract, muscle, skin, and spleen were found to have a relatively high 
level of Rb expression. 
Western blot analysis was undertaken to detect medaka Rb protein by using 
commercially available monoclonal antibody against human Rb. Liver had relatively high 
levels of Rb protein. The 97, 66, and 45 kDa bands were detected in liver. 
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Gastrointestinal tract did not show any Rb protein band. Eye and gill showed a 45 kDa 
band. Brain showed the 97, 66, and 45 kDa bands. The 66 kDa band was highly detected 
in this tissue. Skin and muscle showed approximately 64, 60, and 45 kDa bands. 
Especially, about 180 kDa band was detected in muscle. In the early (1 day after 
fertilization) and late egg stage ( over 6 days after fertilization), an approximately molecular 
weight of 105 kDa was detected. This band was not detected in the fry stage. There were 
additional bands in late egg and fry stage at 80, 64, or 60 kDa. The 45 kDa band was 
shown in both late egg and fry stage. 
A cDNA library from medaka liver has been constructed. The primary phage 
library packaged was about 0. 8 x 106 pfu/µg of vector. This was amplified and the total 
titer for the amplified phage library was 1. 7 x 1 cf pfu/ml. Two cDN A libraries were 
screened by human 505 bp Rb cDNA. One was made in 11. ZAPil by Dr. B. Van. 
Beneden and the other was made in "' gtl 1 by me. In the primary screening of the 
"'ZAPII, 27 putative clones were detected. Following the second screening, a background 
problem developed. All plaques showed positive signals. These signals in the screening 
were due to the hybridization of the pBluescript phagemid to the probe. Lambda gtl 1 
cDNA library was screened using the same method as for the"' ZAPII cDNA library. The 
same background problem occurred in the 11. gtl 1 cDNA library. 
Medaka Rb cDNA probe was developed using RT-PCR. Three fragments were 
obtained and their identity was verified by hybridization experiments. To determine if the 
RT-PCR fragments were medaka Rb cDNA, the fragments were labeled with 32P and used 
as probes. All three fragments crosshybridized to the human 3.8 kb Rb cDNA. Further 
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evidence attesting to the fidelity of RT-PCR was obtained with a Southern blot analysis 
using the fragments as probes. The 469 bp (made by R54 and R32 primers) and 493 bp 
(SHSl and R34 primers) fragments crosshybridized with the medaka genomic DNA 
To investigate the effect of growth factors and hormones on the expression of Rb 
protein in med.aka, primacy tissue cultures from medaka liver were treated with EGF, 
TGF-fH, insulin, or estradioL The result indicated that growth factors and hormones did 
not affect the level of expression of Rb protein in medaka. 
Future study should initially focus on clone of medaka Rb cDNA A medaka 
genomic DNA library has been screened and one positive clone was isolate. The clone is 
being sequenced. ff this clone turns out to be a Rb fragment, the cDNA library can be 
screened using the fragment To answer the ques1ions of where Rb mRNA is being 
synthesized and where it may be func1ioning, the sites where Rb mRNA accumulates 
should be detennined by in situ hybridization using cloned medaka Rb cDNA as a probe. 
The ontogeny of neoplasia in the medaka following chemical carcinogens exposure should 
be explored. The expression of the Rb protein in all tissues during the neoplastic process 
could be traced using Western blot analysis and im.munohistochemist:ry. Tissue culture cell 
line of medaka should be established for the detailed study of the basic properties of 
retinoblastoma. 
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